Congenital Cardiology Solutions (CCS)  by unknown
JACC March 11, 2008  ABSTRACTS - Congenital Cardiology Solutions (CCS)  A83
C
ongenital C
ardiology S
olutions (C
C
S
)
9:00 a.m.
1004-119 Cardiac Twisting of the Human Fetal Left Ventricle and 
Its Relationship to Strain From High Resolution Grey 
Scale Images Analyzed by 2D Speckle Tracking
Boris Tutschek, Ling Hui, Muhammad Ashraf, Christine S. Sahn, Solange Wyatt, Mary S. 
Minette, David J. Sahn, Oregon Health & Science University, Portland, OR
Background: Twisting is an essential component of left ventricular (LV) function. We used 
a new two-dimensional (2D) speckle tracking method to study LV twisting in short axis 
views in normal human fetuses and compared the twist to longitudinal LV strain computed 
from 4-chamber views.
Methods: Thirty-four normal human fetuses between 20 and 36 weeks estimated 
gestational age were studied using a 5.5MHz transducer on a dedicated echocardiography 
system (M3S and Vivid 7, GE Healthcare, Milwaukee, WI). Short axis and long axis views 
of the fetal left ventricle were acquired, exported digitally and analyzed offline using a new 
2D speckle tracking program (EchoPac, GE Healthcare). Global LV rotation in systole was 
measured, and 4-chamber views were analyzed for LV longitudinal strain.
Results: LV systolic counterclockwise (CCW) twisting could be detected in all fetuses 
studied. Mean peak global twist of the fetal cardiac left ventricle between 20 and 36 weeks’ 
gestation was 8.9° CCW (range 4.7° to 12.3°) LV longitudinal strain rates were a mean of 
2.8/sec (range 1.6-4.7/sec) and there was a strong correlation between longitudinal strain 
rates in 4 chamber views and short axis twisting (r = 0.81; p<0.01).
Conclusion: This angle independent 2D speckle tracking method is applicable to fetal echo 
images and should aid study of maturational changes in fetal cardiac muscle function.
ACC.POSTER CONTRIBUTIONS
1004 
Pediatric Cardiology I
Sunday, March 30, 2008, 9:00 a.m.-12:30 p.m.
McCormick Place, South Hall 
9:00 a.m.
1004-117 Diastolic Mechanical Dyssynchrony is Associated 
with Adverse Outcomes in Children with Dilated 
Cardiomyopathy
Mark K. Friedberg, Arshiya F. Mohamed, Mervin Balasingam, Lucy Roche, Paul F. 
Kantor, Hospital for Sick Children, Toronto, ON, Canada
Background: Left ventricular (LV) diastolic mechanical dyssynchrony and its relation to 
clinical status have not been studied in children with DCM.
Methods: We calculated a diastolic dyssynchrony index (DI) (standard deviation of time 
to peak early tissue diastolic velocity in 12 LV segments) in 24 children with DCM and 22 
controls. Similarly we calculated a systolic DI and compared diastolic to systolic motion 
in DCM patients and controls. Based on control results, we selected a DI threshold to 
determine diastolic dyssynchrony and separated DCM patients into those with and those 
without diastolic dyssynchrony and compared cardiac function and clinical outcomes 
between groups.
Results: Diastolic wall motion was more synchronized than systolic wall motion, both in 
controls (8.4±3.5 vs 19.8±7.1 ms, p<0.0001) and in DCM patients (25.5±3.5 vs 42.2 ±7.1 
ms, p< 0.01). The diastolic DI was significantly higher in children with DCM compared 
to controls (25.5±19.2 vs 8.4±3.6 ms, p<0.001). We determined a 17 ms DI threshold 
to indicate presence of diastolic dyssynchrony. Patients who were transplanted or died 
had more LV diastolic dyssynchrony than survivors and DCM patients with diastolic 
dyssynchrony had decreased transplant-free survival as compared to synchronous DCM 
patients (Hazard ratio 6.1, p<0.01).
Conclusions: LV wall motion is more synchronized in diastole than in systole. LV diastolic 
mechanical dyssynchrony is common in pediatric DCM and is associated with decreased 
transplant-free survival. 
9:00 a.m.
1004-118 Application of 4-Dimensional Echocardiography for the 
Evaluation of Fetal Cardiac Ejection Fraction
Ling Hui, Michael S. Schaal, Boris Tutschek, Mary S. Minette, David J. Sahn, Oregon 
Health & Science University, Portland, OR
Background: Because of their unusual shapes, 2D estimates of right and left ventricular 
(RV, LV) volumes and ejection fractions (EF) in fetuses are probably not accurate. EF is 
a routine index for evaluation of cardiac function in children and adults. We evaluated 
the use of 4-Dimensional (4D) echocardiography to evaluate fetal cardiac function and 
develop normal values in this study.
Methods: 4D cardiac fetal data were collected during routine examinations for 58 normal 
fetuses (gestational ages, 16-36 weeks). Optimized dynamic spatiotemporal correlation 
volumes of the fetal thorax and cardiac chambers were rapidly acquired at 8-11 MHz 
on a GE/Voluson 730 Expert ultrasound system. End-systolic and end-diastolic RV and 
LV volumes were later measured using a radial summation technique from epicardial 
and endocardial traces on an offline GE 4D view program. EF was calculated for each 
ventricle.
Results: 52 fetal cardiac 4D volume images were suitable for final statistical analysis. The 
RV and LV volumes increased with gestational age. Although RV volumes (mean ratio 
1.15:1) were slightly larger, there was no significant difference in the EFs for the RV and 
LV. Mean RV EF and LV EF were 66.00% ± 10.88% and 64.34% ± 12.33%, respectively; 
and mean EF remained relatively constant with increasing gestational age.
Conclusions: 4D echocardiography can provide accurate and reproducible measurements 
of fetal RV and LV EFs for evaluation of fetuses with congenital heart disease and those 
with cardiac dysfunction.
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9:00 a.m.
1004-120 Left Ventricular Hypertrophy is Associated with Obesity, 
Male Gender and Symptoms in Healthy Adolescent 
Athletes
Mohammad Reza Movahed, Adolfo Martinez, Mehrtash Hashemzadeh, University of 
Arizona Sarver Heart Center and Southern Arizona VA Health Care System, Tucson, AZ
Background: Obesity has been found to be associated with left ventricular hypertrophy 
(LVH). However, the occurrence of LVH in obese teenage athletes has not been studied. 
The objective of this study was to evaluate the prevalence of LVH and its correlation with 
obesity, gender and symptoms in teenage athletes.
Methods: A total of 1,500 adolescence athletes from California between the ages of 12 
and 20 underwent screening echocardiography. We evaluated associations between 
obesity and LVH (defined as left ventricular wall thickness (LVWT) over12mm, or LV mass 
(LVM) over 215 g or relative wall thickness (RWT) >0.43) and physical symptoms.
Results: Using uni- and multivariate analysis, male gender was associated with increased 
LVWT (OR 4.87, CI2.41-9.82). Obesity was associated with parameters of LVH using 
uni- and multivariate analysis adjusting for age and gender (LVM>215 g occurred in 
10.32% of obese athletes vs. 0.2% of control, (OR 51.33, CI 6.05-433.8), p<0.001, LVWT 
>12mm occurred in 14.6% of obese athletes vs. 3.3% of control (OR 5.00, CI 2.6-9.5, 
p<0.001), RWT>0.43 occurred in 41.4% of obese athletes vs. 15.7% of control ( OR 3.78, 
CI 2.11-6.76, p<0.001). Furthermore, after adjusting for age and gender, reported history 
of shortness of breath, fatigue and leg edema were significantly more prevalent in obese 
athletes and in athletes with LVH.
Conclusion: Obesity is associated with LVH in a population of healthy teenage athletes. 
Furthermore, the presence of LVH was independently associated with many physical 
symptoms suggesting negative effect of LVH on myocardial function.
9:00 a.m.
1004-121 Reverse Kinetics of Circulating Soluble Receptor for 
Advanced Glycation End Products (sRAGE) and its 
Ligand S100A12 in Acute Kawasaki Disease
Keiichi Hirono, Helmut Wittkowski, Thomas Vogl, Fei Ye, Keijirou Ibuki, Kazuyoshi 
Saito, Keiichiro Uese, Fukiko Ichida, Toshio Miyawaki, Johannes Johannes, Dirk Foell, 
University of Toyama, Toyama city, Japan
Background: Kawasaki disease (KD) is an acute systemic vasculitis syndrome of 
children characterized by extensive activation of innate immunity and a potentially lethal 
involvement of coronary arteries. The receptor for advanced glycation end products 
(RAGE) serves as a pattern recognition receptor for a number of endogenous ligands 
which are potent inducers of vasculitis. S100A12 is secreted from activated neutrophils 
which are markedly elevated in KD and play a major role in vasculitic tissue damage. 
Soluble RAGE (sRAGE) is supposed to act as a naturally occurring inhibitor of RAGE 
by neutralizing proinflammatory ligands; S100A12. The relation of S100A12 and sRAGE 
has not yet been analyzed in the context of acute inflammation. The aim of our study was 
to investigate for the first time circulating sRAGE in with KD and compared these data 
directly with concentrations of the proinflammatory RAGE-ligand S100A12.
Methods: We investigated 50 patients with acute KD, and differentiated by response 
to intravenous immune globulin (IVIG) treatment, and examined sequential changes in 
serum levels of RAGE and S100A12 using by ELISA.
Results: We found that patients had decreased levels of sRAGE (553±97 pg/ml, P<0.001) 
during active KD, especially those more severely affected and not responding to treatment. 
In addition, sRAGE correlated negatively to proinflammatory S100A12 (328±106 ng/ml, 
P<0.001) which was found elevated in patients with active KD. The initial serum levels of 
S100A12 were elevated in all patients with KD and decreased within 24 hours of IVIG 
(P<0.01) in the group of 20 responders. In contrast, in 20 non-responders the serum 
S100A12 levels increased after the initial treatment.
Conclusion: Our data suggest that endogenously low levels of sRAGE do not only serve as 
biomarker of inflammation but can also be disease modifying, or even be a susceptibility 
factor itself. Soluble RAGE may block the binding of S100A12 to RAGE on the cell surface 
by neutralizing this proinflammatory protein. Both decreased production and increased 
consumption of sRAGE could be influenced by administration of exogenous sRAGE as 
an antiinflammatory therapeutic strategy.
9:00 a.m.
1004-122 Pulmonary Arterial Capacitance In Children With 
Idiopathic Pulmonary Arterial Hypertension And 
Pulmonary Arterial Hypertension Associated With 
Congenital Heart Disease: Relation To Right Ventricular 
Work, Pulmonary Vascular Resistance And Clinical 
Outcome
*Imran Sajan, Janette Reyes, Brian McCrindle, jia Li, Cedric Manlhiot, Mark Friedberg, 
The Hospital For Sick Children, Toronto, ON, Canada, * The Heart Institute For Children 
at Hope Children’s Hospital / University of Illinois, Oak Lawn, IL
Background: Pulmonary Arterial Capacitance (PAC = Right Ventricular (RV) stroke volume 
/PA pulse pressure, ml/mmHg) predicts mortality in adults with pulmonary hypertension 
(PAH). We compared PAC In children with PAH either associated with congenital heart 
disease (APAH) or those with idiopathic PAH (IPAH). In addition, we assesed the relation 
of PAC to RV work (RVW), RV power, indexed pulmonary vascular resistance (PVRI) and 
clinical outcome.
Methods: Retrospective review of catheterization and clinical data (1996-2007) of children 
(0-18 yrs) with PAH (mean PAP > 25 mmHg), excluding patients with systemic to PA 
shunts, PA stents, major aortopulmonary collaterals or RV outflow tract obstruction. We 
studied the relation of PAC with RV stroke work (stroke volume x systolic PA pressure) 
and RV power (stroke work / PA ejection time). We compared PAC and PVRI between 
IPAH and APAH groups and between children who had heart transplant or death vs those 
who did not.
Results: 14 patients with IPAH, and 21 with APAH were identified with a mean age of 8.7 
+ 5.7 and 6.3 + 5.9 years respectively ( p= 0.2). PA systolic pressure was not significantly 
different between groups (87+22.8 IPAH vs 60+15.4 APAH; p= 0.2). PAC was similar 
between IPAH and APAH ( 0.99+0.35 vs 0.79+0.32 respectively; p= 0.1), although PVRI 
was significantly higher in APAH vs IPAH (19.6+11.2 vs 10.8+ 4.5 p= 0.01). PVRI was 
inversely correlated with capacitance (all pts: r= -0.55; p= 0.001) both in IPAH (r = -0.6 
p=0.02) and APAH (r= -0.5;p=0.02). For the group as a whole, PAC correlated weakly 
with RVW (r=0.36; p=0.02), and inversely correlated with RV power (r=-0.5;p=0.05), while 
PVRI did not correlate with RVW (r=0.08;p=0.6). There was no correlation between PAC 
or PVRI and distance walked in 6 minutes. 31% (11/35) of pts either died or required a 
transplant (3 IPAH; 8 APAH). PAC (0.97 + 0.35 vs 0.89 + 0.34; p= 0.5) and PVRI (13.8 + 
5.7 vs 14.6 +10 ; p= 0.6) were not different between patients with or without the outcome 
of death or transplantation.
Conclusions: PAC is a better surrogate of RV work than PVRI. PAC was similar in children 
with IPAH and APAH and inversely related to PVRI. However, both PAC and PVRI were 
not predictive of transplant or death in this study.
9:00 a.m.
1004-123 Cryptic Chromosomal Abnormalities Identified in 
Children With Congenital Heart Disease
Ashleigh A. Richards, Lane J. Santos, Haley A. Nichols, Bill Crider, Frederick F. Elder, 
Natalie S. Hauser, Andrew R. Zinn, Vidu Garg, University of Texas Southwestern 
Medical Center, Dallas, TX
Background: Congenital heart disease (CHD) is the most common type of birth defect, but 
the etiology for most cases is unknown. Only in a minority of cases are disease-causing 
chromosomal abnormalities identified. CHD often occurs in association with other birth 
defects in the setting of an undefined syndrome and a normal karyotype. We hypothesized 
that a subset of children with CHD and additional birth defects has cryptic chromosomal 
abnormalities that may be uncovered using array-based methodologies.
Methods: We recruited twenty children with diverse forms of CHD and additional birth 
defects who had no chromosomal abnormality by conventional cytogenetic testing. Using 
whole-genome array comparative genomic hybridization (array CGH) we screened this 
population and a matched control population of twenty children with isolated CHD for 
chromosomal copy number variations (CNV).
Results: We discovered 13 novel putative CNV by array CGH. Seven CNV represented 
disease-causing cryptic chromosomal abnormalities in five children with CHD and 
additional birth defects--an incidence of 25%. Chromosomal abnormalities included 
three unbalanced translocations, one interstitial duplication, and one interstitial deletion. 
Chromosomal abnormalities were confirmed by fluorescence in situ hybridization and 
were only identified in children with CHD and an associated neurologic abnormality. 
Three putative CNV were not confirmed by quantitative reverse transcription polymerase 
chain reaction. Three other CNV were confirmed but were present at low frequencies 
in ethnically matched control populations or in unaffected parents, suggesting that they 
were not disease-causing.
Conclusions: Our results suggest that a significant percentage of children with CHD 
and other birth defects, especially neurologic conditions, harbor subtle chromosomal 
abnormalities not detected by current cytogenetic methodologies. We propose that these 
children receive whole-genome array CGH as an adjunct to current genetic testing to 
detect subtle chromosomal abnormalities.
9:00 a.m.
1004-124 Clinical and Electrophysiological Data of Patients with 
Anteroseptal Atrioventricular Accessory Pathway
Béatrice Brembilla-Perrot, Olivier Huttin, Etienne Aliot, François Marçon, Cardiology, 
CHU of Brabois, Vandoeuvre Les Nancy, France
Background: Radiofrequency ablation of atrioventricular accessory pathway (AP) remains 
at risk of complete AV block in the case of anteroseptal (AS) location and its indication 
remains debatable. The purpose of the study was to evaluate the frequency of AS location 
in Wolff-Parkinson-White syndrome (WPW) and the clinical and electrophysiological data 
of these patients.
Methods: Electrophysiologic study (EPS) was performed in 503 pts aged from 6 to 85 years 
(35±17), 297 men, 206 women, recruited for a patent WPW syndrome. The location of AP 
was determined on a 12 lead ECG during atrial pacing at maximal preexcitation according 
to classical criteria. The location was confirmed at EPS. 11 pts were excluded because the 
location remained not clearly defined. EPS was indicated for suspected or documented 
tachycardias (n=264), syncope (n= 68) or was systematic in asymptomatic patients (n= 171).
Results: AS AP location was identified in 34 patients aged 8 to 48 years (7%). Their mean 
age was younger than the age of remaining population (25±13 versus 36±17, p <0.001). 
According to the age, the incidence of AS location was significantly higher in 119 children 
and adolescents (14 %) than after 40 years (3 %) (p < 0.01). There was no AS location 
among 108 patients aged more than 50 years. The maximal rate conducted over AP was 
lower in patients with AS location than in other locations either in control state (174±60 
b/min versus 197±63) (p <0.01) or after isoproterenol (206±71 versus 248±69) (p < 0.01). 
The number of induced reciprocating tachycardia ( 47 % versus 57 %) , atrial fibrillation 
(15% versus 21 %) and malign forms (12% versus 17 %) did not differ significantly in 
patients with AS location and in other patients. Anterograde conduction disappeared 
spontaneously in 3 of 6 patients followed 8±1.5 years, and significantly inceased in 2 
other patients.
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Conclusions: AS AP location in WPW syndrome was more frequent in children than in 
adults. The maximal rate conducted over the AP was lower than in other locations. The 
incidence decreased after 40 years and the AS location was never noted after 50 years. 
This disappearance with age should be taken into account for the indications of AS AP 
ablation, mainly in children.
9:00 a.m.
1004-125 Prevalence of Overweight and Obesity in Children With 
Acquired and Congenital Heart Disease
Rachel Shustak, Sharda McGuire, Colin K. L. Phoon, Anne J. L. Chun, New York 
University School of Medicine, New York, NY
Background: Obesity is a public health issue that may affect children with acquired and 
congenital heart disease (HD) to a greater extent for multiple factors. We determined the 
prevalence of overweight (OW) and obesity (OB) in a pediatric population with HD.
Methods: Retrospective chart review of patients seen by NYU School of Medicine’s 
Pediatric Cardiology Division from 1/1/06 - 12/31/06. Body mass index [BMI] was 
calculated for patients ages 2 - 19 years. BMI ≥ 85th %ile was defined as OW, ≥ 95th 
%ile as OB. A control group with no HD (NHD) was included. Those with comorbidities 
affecting body habitus were excluded.
Results: 795 of 981 patients met inclusion criteria. Overall study OW/OB rates were similar 
to national data (Table 1). There were no significant differences in OW/OB rates between 
HD and NHD groups (p > 0.05). HD males had twice the risk of OB than HD females 
(RR 2.18, 95% CI 1.26-3.78, p = 0.004). In the NHD group, OW/OB rates were similar in 
males and females. Also, post-op HD males had twice the risk of OB vs. HD males with 
no surgery (RR 2.11, 95% CI 1.20-3.71, p= 0.009). The 12-19y HD group had a higher but 
not significantly different rate of OW than the NHD group (27% vs. 20%, p>0.05).
Conclusion: Our OW/OB rates approximate national data indicating that the obesity 
epidemic affects HD patients. Significant differences based on gender, age, and surgical 
status need to be considered in the care of HD patients.
Table 1: Prevalences of Obesity (OB) and Overweight (OW) by Gender and Age
Overall HD (478) NHD (317) National
Total (n=795) OB 13% 12% 15% 17%OW 27% 27% 28% 34%
Male (439) OB 16% 16% 16% 18%OW 27% 26% 29% 35%
Female (356) OB 9% 7% 12% 16%OW 27% 28% 26% 32%
2-5 years OB 13% 10% 20% 14%OW 30% 28% 36% 26%
6-11 years OB 13% 11% 14% 19%OW 28% 26% 31% 37%
12-19 years OB 13% 13% 12% 17%OW 24% 27% 20% 34%
9:00 a.m.
1004-126 Feasibilty of Transesophageal Electrophysiologic Study 
in a Child 6 to 10 Years Old for Wolff-Parkinson-White 
Syndrome in Out-Patient Clinic
Béatrice Brembilla-Perrot, Nacima Benzaghou, Jean Louis Cloez, Cécile Marchal, Sonia 
Ammar, Charif Tatar, Etienne Aliot, Leice Darwiche, Olivier Huttin, Frédéric Chometon, 
Anne Tisserand, Jean Paul Lethor, François Marçon, Cardiology, CHU of Brabois, 
Vandoeuvre Les Nancy, France
Background : The evaluation of Wolff-Parkinson-White syndrome (WPW) is recommended 
in children aged more 5 years. Invasive electrophysiological study (EPS) is generally 
used, with the rislks of catheterization, the need of anesthesia and hospitalization. The 
purpose of the study was to determine the feasibility of transesophageal EPS in a child 
between 6 and 10 years in out-patient clinic.
Methods: EPS was indicated in 15 children, 6 girls, 9 boys aged 6 to 10 years, mean age 
8.5±1 with a manifest WPW either for no documented tachycardia (n=4), unexplained 
dizziness (n=1) or for a sportive authorization in 10 asymptomatic children. Two of the last 
children had a history of permanent tachycardia after the birth but were asymptomatic 
since the age of one year without drugs.
Results: EPS was performed in all children, generally in presence of the parents to 
reassure the child. The catheter was passed by mouth after explanations. In one child, 
throat anesthesia was used to avoid nausea reflex. Only programmed stimulation at cycle 
length of 380 ms was performed in 6 children to avoid high rates of pacing when the 
conduction through the accessory pathway (AP) and normal AV system was evaluated. 
Isoproterenol was not required in 5 children, because they developed a catecholaminergic 
sinus tachycardia. The AP refractory period was determined in all children between 
200 and 270 ms. Orthodromic reentrant tachycardia (RT) was induced in all children 
complaining of tachycardia (n=4), in 3 asymptomatic children but 2 of them had the history 
of tachycardia after the birth and in the child with dizziness. Rapid antidromic tachycardia 
was induced in this last child with dizziness. Atrial fibrillation was never induced.
Conclusions: Esophageal EPS can be performed without sedation in a young child 6 to 
10 years old. The presence of parents is recommended and the protocol of stimulation 
should be shortened and adapted at each child according to its anxiety which favors a 
catecholaminergic reaction. Hospitalization, general anesthesia, risks of catheterism and 
X rays use were avoided. RT can be easily induced by the technique in some of them.
9:00 a.m.
1004-136 IS THE MECHANISM OF SUPRAVENTRICULAR 
TACHYCARDIA IN PEDIATRICS INFLUENCED BY AGE, 
GENDER OR RACE?
Rishi G. Anand, George F. Van Hare, Geoffrey L. Rosenthal, Christopher S. Snyder, 
Ochsner Clinic Foundation, New Orleans, LA, Stanford University, Palo Alto, CA
Introduction: Age and gender influences the mechanism of supraventricular tachycardia 
(SVT) in adults. The purpose of this study was to determine if gender, age or race impacts 
the mechanism of SVT in pediatric patients.
Methods: A search of the Pediatric Electrophysiology Registry identified patients whom 
had undergone a procedure from ‘89 - ‘04. Pts were grouped into categories based upon 
age: < 7, 7-<12, and >12-18, race and gender.
Results: There were 3,554 patients (< 7=378, 7-<12=964, 12-18=2212) with 1948 males 
(M), 1606 females (F), 2,916 White, 266 Black, 248 Hispanic, 63 Asian and 61 Other. 
For accessory pathway (AP) tachycardias, there were 2,417 pts (1404M) and for AV 
node reentry tachycardia (AVNRT) there were 1,137 pts (544M). Significant differences 
were found in sex distribution between AP (845M/571F) and AVNRT (353M/443F) in 
the >12-18 age group with females more likely to have AVNRT than AP (p<0.0001). 
When all data was combined, females are still more likely to have AVNRT (593/1137) 
than AP (1013/2417) (p<0.0001). Additional significant difference was identified when 
comparisons were made between Whites and Blacks for AP (White=558, Black=44) vs. 
AVNRT (White=209, Black=32) in age group 7-<12, with Whites being more likely to have 
AP (p<0.025).
Conclusions: The mechanism of SVT in pediatric patients is affected by gender, age, and 
race. Females are more likely to have AVNRT than males. Older females, >12-18 year 
of age, are more likely to have AVNRT than AP. Whites were more likely to have an AP 
then Blacks.
ACC.ORAL CONTRIBUTIONS
801 
Pediatric Cardiology and Cardiothoracic 
Surgery
Sunday, March 30, 2008, 1:00 p.m.-2:00 p.m.
McCormick Place, Room S405
1:00 p.m.
801-3 The Changing Epidemiology of Pediatric Infective 
Endocarditis: A Comparison Across 74 Years at a 
Single Children’s Hospital
Lauren B. Rosenthal, Kristina Feja, Stephanie Levasseur, Luis Alba, Welton M. Gersony, 
Lisa Saiman, NewYork-Presbyterian Hospital, Columbia University Medical Center, New 
York, NY
Background: Previous reviews from our institution described changes in the epidemiology 
of pediatric infective endocarditis (IE) reflecting shifts in medical practice over 6 decades. 
We hypothesized that continuing changes in the care of children with complex medical 
problems, especially congenital heart disease (CHD), would further alter the epidemiology 
of pediatric IE.
Methods: A retrospective review was conducted of patients <= 18 years-old treated for 
IE at the Children’s Hospital of NewYork-Presbyterian from 1992-2004. These data were 
compared with prior reports from our institution.
Results: Demographic data, risk factors, predominant pathogens and crude mortality 
in the 3 eras are displayed. In Era 3, the median age at diagnosis decreased to 1.6 
years due to a marked increase in IE in < 2 year-olds. Trends noted in Era 2 (decreased 
rheumatic heart disease and increased CHD) were sustained in Era 3. In Era 3, the 
proportion of non-streptococcal non-staphylococcal pathogens increased, consistent with 
nosocomial acquisition. The crude mortality in the antibiotic era was largely unchanged. 
However, in Era 3, nosocomial IE accounted for a greater percentage of deaths than 
community-acquired IE.
Conclusions: The epidemiology of pediatric IE continues to evolve. The profile of the 
modern child with IE is younger, usually has underlying CHD, is more likely to be infected 
with a non-streptococcal non-staphylococcal organism and is at increased risk of dying 
from nosocomial than community-acquired IE.
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Era 1 
1930-1959 
N = 58
Era 2  
1977-1992 
N = 62
Era 3 
1992-2004 
N = 86
Male 19 (33%) 39 (63%) 44 (51%)
Age 
Median (years) 
< 2 years of age 
Premature
- 
8 
5 (9%) 
Unknown
- 
8.2 
20 (32%) 
9 (15%)
- 
1.6 
46 (53%) 
18 (21%)
Underlying heart disease 
Rheumatic heart disease 
Congenital heart disease 
-Prior heart surgery 
--Early post-operative IE (<= 2 months) 
Other
58 (100%) 
18 (31%) 
40 (69%) 
12 
9 
0
43 (70%) 
3 (7%) 
40 (93%) 
18 
4 
0
71 (83%) 
1 (1%) 
66 (93%) 
45 
21 
4 (6%)
Structurally normal heart 
Nosocomial IE 
-Central venous catheter
Not applicable 
- 
-
19 (30%) 
13 
11
15 (17%) 
9 
7
Major pathogens 
Streptoccocal species 
Staphylococcus aureus 
-MRSA 
Coagulase-negative staphylococci 
Enterococcal species 
Gram negative bacilli 
Candida species 
Culture negative IE
- 
40 (69%) 
10 (17%) 
0 
0 
0 
0 
0 
3 (5%)
- 
14 (23%) 
24 (39%) 
8 
7 (11%) 
1 (2%) 
4 (6%) 
6 (10%) 
4 (6%)
- 
26 (30%) 
17 (20%) 
3 
27 (31%) 
11 (13%) 
12 (14%) 
11 (13%) 
4 (5%)
Crude mortality 
Pre-antibiotic era 
Antibiotic era 
Nosocomial IE 
Community-acquired IE
- 
86% 
32% 
Unknown 
Unknown
- 
Not applicable 
21% 
Unknown 
Unknown
- 
Not applicable 
23% 
38% 
5%
1:15 p.m.
801-4 Screening Data from the Pediatric Heart Network Infant 
Single Ventricle Trial: Association of Single Ventricle 
Physiology with Preterm Birth and Low Birth Weight
Richard Williams, Chitra Ravishankar, Victor Zak, Andrew Atz, William Border, Jami 
Levine, Jennifer Li, Lynn Mahony, Seema Mital, Gail Pearson, Ashwin Prakash, Daphne 
Hsu, for the Pediatric Heart Network, University of Utah, Salt Lake City, UT
Background: Screening data from the Pediatric Heart Network Trial of ACE Inhibition in 
Infants with Single Ventricle (SV) provides an opportunity to profile a large number of 
neonates with SV physiology at 10 cardiac surgical centers. Our hypotheses were that SV 
infants are more likely to be preterm (<37 weeks), small for gestational age (SGA, <10th 
%tile) and low birth weight (LBW, <2500 gm) than the general population, and that those 
with hypoplastic left heart syndrome (HLHS) are more likely to be preterm, SGA and LBW 
than those without HLHS.
Methods: All neonates (<45 days of age) with SV screened for trial eligibility (8/03 to 3/07) 
were reviewed. HLHS and non-HLHS were compared using t-test and Wilcoxon methods 
for continuous variables and Fisher exact test for categorical.
Results: 1245 neonates were screened, 61% male (63 to 266 /center). Diagnoses were 
HLHS (49%), RV dominant atrioventricular septal defect (10%), tricuspid atresia (9%), 
pulmonary atresia with intact ventricular septum (8%), double inlet LV (7%), and other 
(17%). Preterm birth occurred in 16% (vs 12% in US), 18% were LBW (vs 8% in US) and 
21% were SGA. Proportion SGA differed by race (White 19%, African American 27%, 
Asian 27%, p=0.019), but not between HLHS and non-HLHS (Table).
Conclusions: In this large prospective cohort of neonates with SV, nearly half had HLHS. 
Preterm birth, SGA and LBW were more prevalent compared to the general population. The 
impact of these factors on growth and development in infants with SV requires further study. 
Race (%)*
Median Gest 
Age (weeks)
SGA 
(%)
Male 
(%)* White
African 
American Asian Other Other
All 
(n = 1245) 38.0 21.2 60.7 73.1 16.9 3.5 6.5 6.5
HLHS 
(n = 606) 38.0 19.8 64.7 77.6 15.7 2.6 4.1 4.1
Non-HLHS 
(n = 639) 38.0 22.5 57.0 68.9 18.0 4.4 8.8 8.8
*p<0.01 for HLHS vs. non HLHS.
1:30 p.m.
801-5 Poor interstage weight gain is common and adversely 
affects short-term outcome after the bidirectional 
Glenn shunt
Jeffrey B. Anderson, Will Border, Carole Lannon, Karen Uzark, Phil Khoury, Robert 
Beekman, Cincinnati Children’s Hospital, Cincinnati, OH
Background: Malnutrition has been described in infants with single ventricle physiology 
undergoing staged palliation, however little is known regarding its impact on cardiac 
surgical outcomes. We sought to assess the effect of nutritional status at the time of 
bidirectional Glenn (BDG) procedure on short-term outcomes including length of ICU 
stay, ventilator time, chest tube duration, total length of hospital stay and compliance with 
evidence-based clinical pathway time-to-discharge.
Methods: Retrospective chart review of all infants who underwent BDG procedure at 
our institution between 7/2001 and 11/2006. Nutritional status was determined by birth 
weight, weight at BDG and weight percentile at BDG. Standard preoperative risk factors 
including mean pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR) 
and ventricular end-diastolic pressure (VEDP) were recorded. The impact of nutritional 
and standard risk factors on surgical outcome was examined using univariate and 
multivariate analyses.
Results: 98 infants were included for analysis (age range at BDG: 3-21 months, mean = 6 
+/- 3). The distribution of weight percentiles at birth compared to BDG showed a notable 
shift toward the lower percentiles. A weight < 3%ile was present in 16% of patients at birth, 
but in 46% at admission for BDG. Patients with lower weight at BDG had longer ICU stays 
(p<0.003), ventilator times (p<0.02), chest tube durations (p<0.003) and a decreased 
likelihood of meeting clinical pathway discharge goals from both the ICU (p<0.04) and the 
hospital (p<0.004). Those infants who were < 10%ile for weight at BDG had longer ICU 
stays (p<0.06), chest tube duration (p<0.06) and had decreased likelihood of meeting 
discharge goals from both the ICU (p<0.08) and the hospital (p<0.04). In a multivariate 
anaysis that included age, weight, PAP, PVR, VEDP, O2 saturation and bypass time, 
weight (p<0.05) and bypass time (p<0.03) were the only significant independent factors 
to predict success at meeting clinical pathway discharge goals.
Conclusions: Weight gain between birth and BDG in infants with a single ventricle is 
often suboptimal and low pre-operative weight negatively impacts short-term surgical 
outcomes.
1:45 p.m.
801-6 Comparing Balloon Angioplasty, Stenting and Surgery 
in the Treatment of Aortic Coarctation
Ralf Holzer, Joanne L. Chisolm, Sharon L. Hill, John P. Cheatham, NATIONWIDE 
CHILDREN’S HOSPITAL, Columbus, OH, Congenital Cardiovascular Interventional 
Study Consortium (CCISC), Detroit, MI
Background: Therapeutic strategies for aortic (re)coarctation (CoA) include balloon 
angioplasty (BA), implantation of endovascular stents and surgical repair. Prospective 
data is scarce and treatment is frequently dependent on institutional and/or operator 
preference. Methods: Between 09/2002 and 08/2007, the Congenital Cardiovascular 
Interventional Study Consortium (CCISC), prospectively collected data on 226 procedures 
(proc) performed in 33 centers (BA: n=50, Stent: n=147, Surgery: n=29). Median age 
was 13.7yr (BA: 10.8yr, Stent: 14.8yr, Surgery: 7.5yr p=0.0003). 97/226pts (42.9%) had 
recurrent CoA (28pts with previous BA/stent therapy). Results: All techniques achieved a 
significant immediate gradient reduction across the CoA. The median UL/LL BP gradient 
at hospital discharge was significantly lower after stent placement (2mmHg), when 
compared to BA (9mmHg) or surgery (10mmHg) (P<0.0001). 96/226pts (42.5%) were 
discharged on antihypertensive medication (BA: 26%, Stent: 64.6%, Surgery: 75.9%, 
p<0.0001). Periprocedural adverse events were documented in 31/226proc (13.7%) 
(BA: 14%, Stent: 12.9%, Surgery: 17.2%) and median time to hospital discharge was 
1d (0-40d) (BA/Stent: 1d, Surgery: 4d, p<0.0001). Median follow up was 1.1yr (35d-5yr). 
58/226pts (28.8%) had CT, MRI or diagnostic cath at a median interval of 1yr (1d-3.4yr), 
documenting aneurysm formation or dissection in 1pt and recurrent obstruction in 8pts. 
Reinterventions were required in 15/226pts (6.6%) at a median interval of 203d (1d-4.4yr), 
14 after stent placement, and 11/14 (78%) as planned redilations. At recent follow up 
antihypertensive medication was required in 36.9% (BA: 0%, Stent: 25%, Surgery: 50%), 
and the median UL/LL BP gradient was 2mmHg (BA: 5mmHg, Stent: 2mmHg, Surgery: 
3mmHg). Conclusion: 1) Stent therapy appears to be associated with the lowest short-
and medium term UL/LL blood pressure gradients. 2) Surgical repair of CoA may require 
longer postprocedural antihypertensive therapy when compared to balloon angioplasty or 
stenting. 3) All techniques have a comparable rate of periprocedural adverse events. 4) 
Long-term follow up data is required.
ACC.POSTER CONTRIBUTIONS
1011 
Pediatric Cardiology II
Sunday, March 30, 2008, 1:00 p.m.-4:30 p.m.
McCormick Place, South Hall 
1:00 p.m.
1011-117 Ultrafast Cardiac Magnetic Resonance Imaging 
of Infants < 6 Months of Age Without Sedation or 
Cardiac Anesthesia in < 5 Minutes: Competition for 
Computerized Tomography?
Mark A. Fogel, Matthew Harris, Christine Harris, The Childrens Hospital of Philadelphia, 
Philadelphia, PA, The Georgia Institute of Technology, Philadlephia, PA
Background: Cardiac magnetic resonance (CMR) requires pts to remain motionless 
which can be problematic in children. This is accomplished with either deep sedation 
(DS) or cardiac anesthesia (CA); it would be useful to perform CMR without DS or CA. 
In addition, for CMR to compete with computerized tomography (CT), it would helpful to 
speed up the examination.
Purpose: To determine if infants < 6 months of age can undergo successful CMR without 
DS or CA.
Methods: 12 pts ages 3.2 + 1.2 months underwent CMR without DS or CA to determine 
whether a vascular ring was present utilizing ultrafast techniques. Pts had an intravenous 
line and ECG leads placed, fed, swaddled and placed in the scanner. Ultrafast single shot 
steady state free precession (USSFP), dark blood imaging and 3-dimensional gadolinium 
were performed.
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Results: In 11, studies were completed in < 5 minutes and were diagnostic; infants 
fell asleep in the scanner. USSFP, where the major diagnostic information is obtained, 
was performed in < 30 seconds. 10 pts had a vascular ring (eg double aortic arch) with 
significant tracheal narrowing and 1had a left aortic arch. See figure. The 12th pt never fell 
asleep and was referred for DS.
Conclusion: Infants < 6 months of age can be successfully imaged by CMR utilizing 
ultrafast techniques without DS or CA and can successfully compete with CT in this 
age group. This study demonstrated that the radiation and the sedation/CA medication 
exposure is not necessary and that the imaging time can be markedly reduced on par 
with CT.
1:00 p.m.
1011-118 Novel Method of Pressure:Volume Loop Analysis by 
Three-Dimensional Echocardiography in Congenital 
Heart Disease
G. Hamilton Baker, Jeremy Ringewald, Girish Shirali, Varsha Bandisode, Tim McQuinn, 
Medical University of South Carolina, Charleston, SC
Background: Pressure:volume loop (PVL) analysis provides valuable indices of 
myocardial pump function. Conductance catheters are currently impractical in children, 
limiting the clinical use of PVL analysis. We evaluated a novel method of PVL analysis 
using simultaneous 3-dimensional echocardiocardiography (3DE) and catheterization.
Methods: PVLs were constructed in 8 patients including 5 in whom PVLs were acquired 
before and after catheter intervention. 3DE left ventricular (LV) full volumes were acquired 
with simultaneous LV pressure recording by fluid-filled catheters (Series IV, WITT 
Biomedical). LV volume throughout the cardiac cycle was calculated with volumetric 
software (3DQ Adv, Philips Medical). Volume and pressure data were synchronized by 
electrocardiogram. Stroke work (SW) was calculated as the area within the PVL. In 3 
patients, the preload alteration associated with PDA occlusion allowed calculation of 
preload recruitable SW.
Results: The patients’ diagnoses included: PDA (n = 4); atrial septal defect (n = 2); aortic 
stenosis (n = 1); coarctation of the aorta (n = 1).
Figure 1. Example PVL and Data
Conclusions: These preliminary data demonstrate that PVL analysis by 3DE and 
catheterization is feasible and provides the potential to calculate useful indices of 
contractility, such as preload recruitable SW. Combination of this novel methodology with 
controlled load alterations may provide a clinically practical method for PVL analysis.
1:00 p.m.
1011-119 Waist Circumference, Body Mass Index, & Cardiac 
Parameters in Children & Adolescents
S. Ken Mehta, Nancy Richards, Richard Lorber, Geoffrey L. Rosenthal, Fairview & 
Children’s Hospital, Cleveland Clinic, Cleveland, OH
Background: Waist Circumference (WC) may predict cardiovascular risk better than 
Body Mass Index (BMI) in adults. The relationships of WC and cardiac parameters 
have not been reported in children. In this study, we explore the associations between 
waist circumference, BMI, and several echocardiographic parameters in children and 
adolescents.
Methods: Forty-nine subjects, age 3-19 years without clinically apparent cardiovascular 
pathology were studied using conventional echocardiography methods and pulsed Tissue 
Doppler Echocardiography (TDE). Correlations, t-tests, and regressions were used for 
statistical testing.
Results: Based on regression models, WC was the best predictor of TDE measures of 
diastolic function. WC was significantly associated with the ratio of early left ventricular 
(LV) longitudinal myocardial velocity (Ea) over late velocity from atrial contraction (Aa) at 
the interventricular septum (P=0.025) and inferior wall (P=0.001). Both BMI and WC were 
independent predictors of left ventricular mass index2.7 (P=0.001 & P=0.05 respectively). 
Left ventricular concentric remodeling was only associated with BMI (P=0.007).
Tissue Doppler parameters WC > 90
th
 percentile 
(N=17)
WC < 90th 
percentile 
(N=32)
P value
Waist circumference (cm) 97 ± 15.2 73 ± 12.9
Age (years) 13.3 ± 3.2 13.3 ± 3.9
BMI (kg/m2) 28.9 ± 5.4 19.8 ± 4.0 0.001
BSA (M2) 1.8 ± 0.4 1.5 ± 0.4 0.013
Heart rate 78 ± 12 75 ± 11 0.311
LV mass index (g/m2.7)* 39.6 ± 8.5 32.4 ± 6.3 0.002
LV concentric remodeling 7 (41%) 1 (3%) 0.001
Mitral valve blood flow
- Peak MV-E (cm/s) 94.5 ± 14.6 92.5 ± 16.1 0.689
- Peak MV-A (cm/s) 52.7 ± 7.7 43.9 ± 13.6 0.007
- MV-E / MV-A 1.8 ± 0.4 2.4 ± 1.2 0.031
Interventricular Septum
- Peak Septal-Ea (cm/s) 13.4 ± 2.1 15.0 ± 2.1 0.014
- Peak Septal-Aa (cm/s) 7.1 ± 1.8 6.5 ± 1.3 0.154
- Peak Septal-Ea / Peak Septal-Aa 2.0 ± 0.5 2.4 ± 0.6 0.019
- MV-E / Peak Septal-Ea 7.1 ± 0.8 6.2 ± 1.1 0.005
Lateral wall
- Peak Lateral-Ea (cm/s) 18.0 ± 3.1 20.4 ± 4.0 0.035
- Peak Lateral-Aa (cm/s) 7.2 ± 1.4 6.8 ± 1.4 0.465
- Peak Lateral-Ea / Peak Lateral-Aa 2.6 ± 0.6 3.1 ± 0.9 0.039
- MV-E / Peak Lateral-Ea 5.3 ± 0.8 4.6 ± 0.8 0.005
Conclusions: While higher WC was negatively associated with TDE measures of left 
ventricular diastolic function in children, BMI was associated with left ventricular mass and 
geometry. The long-term implications of these associations require further exploration.
1:00 p.m.
1011-120 Real time three-dimensional echocardiography 
provides new insight into the mechanisms of tricuspid 
valve regurgitation in the patient with hypoplastic left 
heart syndrome
Ken Takahashi, Akio Inage, Richard Thompson, Ivan Rebeyka, David Ross, Jeffrey F. 
Smallhorn, University of Alberta, Edmonton, Canada
Background:Although tricuspid regurgitation (TR) in hypoplastic left heart syndrome 
(HLHS) has an important negative impact on outcome, the mechanisms are still unclear.
Methods: Real time 3-dimensional echocardiography was performed in 29 patients 
with HLHS (aged 1 month to 10 years, mean 3.6 years) (6 post first-stage, 10 post 
cavopulmonary shunt, 13 post Fontan). Using a TomTec offline system we manually 
marked 30 points around the annulus. The tip of papillary muscle was noted at mid 
systole. Finally, the surface of the TV leaflets were traced. We measured the volume of 
leaflet prolapse and tethering, the annular and septal leaflet area and the papillary muscle 
(PM) position .
Results: 16 patients had moderate TR (Group 1) (6:prolapse, 6:tethered leaflets) and 13 
patients mild TR (Group 2) (3:prolapse). The annular area at midsystole was greater in 
Group1 than in Group2, even when adjusted for body surface area (BSA). The prolapse 
and tethering volume in group 1 was greater than group 2 (p<0.05) even when adjusted 
by BSA (p<0.05). In group 1 lateral displacement of either the anterior or posterior PM 
was associated with anterior or posterior leaflet tethering (p<0.001 and p<0.05). The 
septal to total leaflet area in patients with prolapse was smaller than in those without 
prolapse (p<0.05)
Conclusions: In HLH significant TR is associated with lateral PM displacement and 
subsequent leaflet tethering, a small septal leaflet and a larger prolapse volume. These 
findings may impact on future surgical management. 
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1:00 p.m.
1011-121 No Documented Tachycardia in Children Without 
Preexcitation Syndrome; Results of Transesophageal 
Electrophysiological Study
Béatrice Brembilla-Perrot, Jean Dominique Luporsi, Jean Paul Lethor, Anne Tisserand, 
Etienne Aliot, Christian De Chillou, Sonia Ammar, Juanico Cedano, Olivier Huttin, Charif 
Tatar, Nacima Benzaghou, Frédéric Chometon, Laurent Groben, Philippe Admant, 
François Marçon, Cardiology, CHU of Brabois, Vandoeuvre Les Nancy, France
Background: Symptoms in children are often difficult to interpret. In those complaining of 
tachycardias with abrupt beginning, non-invasive studies can be negative. The purpose 
of study was to report the results of transesophageal electrophysiological study (EPS) in 
children complaining of tachycardia, but with normal non-invasive studies.
Methods: 70 children and teenagers aged 7 to 19 years (mean 15±3), 29 boys, 33 girls 
were consecutively recruited for possible paroxysmal supraventricular tachycardia (SVT). 
Tachycardias were not documented. The ECG was normal. Holter monitoring and exercise 
testing were negative and echocardiogram was normal; 20 children had dizziness or 
syncope associated with tachycardias. EPS was performed in the non sedated state in 
the out-patient clinic and consisted of atrial pacing up to 2nd d AV block, programmed 
atrial stimulation with 1 and 2 extrastimuli in control state and after isoproterenol.
Results: EPS was performed in all children but one with syncope. The mean time of study 
was 18±5 min. Radiation was not used. EPS remained negative in 20 children, 9 boys, 
11 girls aged 7 to 19 years (mean 15±3). AV nodal re-entrant tachycardia (AVNRT) was 
induced in 35 children; 10 of them had syncope. A Wolff-Parkinson-White syndrome 
(WPW) related to a left lateral accessory pathway (AP) was identified in 3 children 
during atrial pacing and an atrioventricular re-entrant tachycardia (AVRT) was induced. 
AVRT was induced in 10 other children without anterograde conduction over the AP nor 
syncope. Verapamil-sensitive ventricular tachycardia was induced in one 16 year-old boy. 
The factors of induction of tachycardia were the older age (16±2 years versus 14±4) and 
the absence of syncope (80% versus 55 %). During a mean follow-up of 3±1 years, none 
child with a negative study developed documented tachycardia.
Conclusions: Transesophageal EPS was a rapid and low-cost method to prove the nature 
of paroxysmal tachycardia in children and teenagers with a normal ECG and to find 
a WPW syndrome not visible in sinus rhythm. A tachycardia was induced in 71 % of 
them. However, in the case of associated syncope, systematic head-up tilt test should be 
performed before EPS.
1:00 p.m.
1011-122 Palpitations as an Indication of Heart Disease in 
Children
Sharon Seltzer, Thomas Klitzner, Parvin Dorostkar, University of California Los Angeles, 
Los Angeles, CA, Rainbow Babies and Children’s Hospital, Cleveland, OH
Background: The complaint of palpitations is common in children, but its correlation 
to underlying cardiac pathology in children has yet to be investigated. This study was 
designed to determine the prevalence of underlying heart disease in children without a 
previous diagnosis who complain of palpitations. It further seeks to identify historical and/
or clinical variables that may be predictive of underlying heart disease in these patients.
Methods: A retrospective chart review was conducted in all patients over a two-year 
period who were referred for evaluation by a pediatric cardiologist with a chief complaint 
of palpitations. Patients with known heart disease were excluded. Historical and clinical 
variables, as well as further investigative modalities used by the cardiologists, were 
analyzed for their value as predictors of underlying heart disease.
Results: 183 patients met criteria for the study; a diagnosis was made in 162 cases. Thirty-
nine patients (21%) were found to have structural heart disease or a rhythm disturbance 
of clinical significance, consisting of supraventricular tachycardia (N=15), pre-excitation 
(N=9), Long QT Syndrome (N=6) and ventricular tachycardia (N=2; 2 patients each had 
aortic root dilation, atrial septal defects and mitral valve prolapse. One patient was found 
to have an anomalous left coronary artery. No patient had more than one diagnosis. 
5 patients were found to have potentially lethal arrhythmias after they were placed on 
medication for attention deficit disorder. There were no other historical or clinical variables 
that correlated significantly with underlying heart disease. The only useful diagnostic 
modality in our study was electrocardiogram (ECG), with a specificity of 82%.
Conclusions: This study suggests that the prevalence of underlying cardiac pathology 
in previously healthy patients evaluated for palpitations is 21%. In addution, the only 
useful investigative tool for diagnosis is ECG. The high prevalence of clinically significant 
arrhythmia in patients placed on certain psychotropic medications suggests that an ECG 
should be performed in patients for whom a medication with potential cardiac side-effects 
is under consideration.
1:00 p.m.
1011-123 Catheter Closure of Large Patent Ductus Arteriosus in 
Small Infants ≤ 5 Kg with Amplatzer Duct Occluder
Edwin Francis, Shehan Pererra, BRJ Kannan, Krishna R. Kumar, Amrita Institute of 
Medical Sciences and Research Centre, Cochin, India
Background:Catheter closure of large patent ductus arteriosus (PDA)with occlusive 
devices is technically challenging in small infants and there is potential for protrusion into 
neighboring structures (aorta and pulmonary artery)
Objectives: To describe our institutional experience with catheter closure of large PDA in 
symptomatic infants weighing ≤ 5 kg.
Methods:Case selection for the device was determined by the patients weight and the 
anticipated device size (determined through echocardiography). Salient features of the 
technique included extrusion of the device in the aorta close to the duct ampulla and 
partial deployment of the aortic retention disc in the duct ampulla.
Results:Of 440 patients undergoing catheter closure of PDA during the study period 
(October 2004- August 2007) 62 were ≤ 5 kg, 16 infants (age: 2-9 months; median: 3 
months; weight 4.1±0.85 kg) underwent catheter closure of PDA with the Amplatzer duct 
occluder (size range: 6-4 to 12-10) and remaining 46 underwent coil occlusion. All patients 
were symptomatic with clinical features of significant heart failure, recurrent pneumonia 
or growth failure. Mean pulmonary artery pressure was elevated in all (41±13 mm Hg; 
mean aortic pressure: 59±10 mm Hg). One patient had refractory bronchopneumonia 
requiring mechanical ventilation prior to the procedure. Successful closure was achieved 
in all patients with a median fluoroscopic time of 7 min (range: 4-20 min). Arterial access 
was avoided in 5 patients. Two patients had transient lower limb pulse loss, one of whom 
required thrombolysis. A descending aortic gradient of 10 mm Hg was seen immediate 
post procedure in one patient that resolved on follow up. No flow disturbance was 
recorded in the descending aorta in remaining patients. All are well on follow up (3-38 
months) with no residual flows.
Conclusions: Transcatheter closure of PDA with occlusive devices is feasible with 
encouraging short-term results in selected infants weighing ≤ 5 kg.
1:00 p.m.
1011-124 Leftward Displacement of Septum Primum in 
Hypoplastic Left Heart Syndrome
Matthew V. Park, Raymond T. Fedderly, Peter C. Frommelt, Michelle A. Frommelt, 
Andrew N. Pelech, Robert DB Jaquiss, Kathy A. Musatto, James S. Tweddell, Medical 
College of Wisconsin, Wauwatosa, WI, Children’s Hospital of Wisconsin, Wauwatosa, WI
Background: Embryologic development of atrial septum primum antedates formation 
of the atrioventricular and semilunar valves. Leftward displacement of the superior 
attachment of septum primum (LDSP) has only been described in hypoplastic left heart 
syndrome (HLHS). This study reports the frequency of LDSP in HLHS and correlates 
LDSP with other echocardiographic features of HLHS.
Methods: We reviewed preoperative echocardiograms for 72 consecutive pts with classic 
HLHS from 1996 - 2002 at our institution. One pt was excluded for inadequate imaging. 
Data for the 71 pts included: the size, location, and Doppler gradient across the atrial 
septal defect; location of attachment of septum primum, size and patency of the aortic 
valve (AoV) annulus, size and patency of the mitral valve (MV) annulus, ascending aorta 
diameter (AAD) and left ventricular end diastolic dimension (LVEDD). Patients were 
categorized into 3 groups: aortic atresia/mitral atresia, aortic atresia/mitral stenosis, and 
aortic stenosis/mitral stenosis.
Results: LDSP was seen in 46 of 71 pts (64%). By diagnostic group, 32/35 pts with aortic 
atresia/mitral atresia had LDSP (91%) compared to 10/19 aortic atresia/mitral stenosis 
pts (53%), and 4/17 aortic stenosis/mitral stenosis pts (24%), p < 0.05. AoV patency 
was seen in 4/46 (9%) pts with LDSP compared to 13/25 (52%) pts with normal atrial 
attachment, p<0.005. Mean left heart variables in LDSP vs. normal attachment were (mm): 
AoV annulus 2.24 vs. 3.83, AAD 2.34 vs. 4.1, MV annulus 3.21 vs. 6.48, and LVEDD 6.38 
vs. 13.83. By two-way ANOVA analysis of diagnostic category vs. atrial septal attachment 
with interaction, MV annulus and AAD were independently predicted smaller by LDSP vs. 
normal atrial attachment, p<0.05. Non-significant factors included: AoV annulus, LVEDD, 
atrial septal defect size and Doppler gradient.
Conclusions: LDSP correlates with more severe maldevelopment of the left heart in pts 
with HLHS. As formation of septum primum precedes the development and growth of the 
intracardiac valves, we speculate that LDSP may be an initiating event in the development 
of HLHS. In addition, prenatal identification of LDSP may help direct planning of potential 
in utero therapies. 
1:00 p.m.
1011-125 Risk Factors for Preoperative Death in Neonates With 
Prenatally Diagnosed Congenital Heart Defects
Sinai C. Zyblewski, Girish Shirali, Geoff Forbus, Andrew Atz, Betsy Hill, Anthony 
Hlavacek, Medical University of South Carolina, Charleston, SC
Background: Fetuses with congenital heart defects (CHD) frequently have non-cardiac co-
morbidities. However, there is a paucity of data regarding the potential impact of such co-
morbidities on mortality. We hypothesized that amongst neonates with prenatally diagnosed 
CHD, these non-cardiac co-morbidities are risk factors for death prior to planned cardiac surgery. 
Additionally, we sought to identify demographic factors that affect this same outcome.
Methods: We reviewed all cases of prenatally diagnosed CHD from 08/1998 to 12/2006 
at our center. The following variables were studied as potential risk factors for neonatal 
death prior to cardiac surgery: race, gender, insurance status, gestational age at birth, 
birth weight, univentricular vs. biventricular physiology, accuracy of prenatal diagnosis, 
chromosomal abnormality, and extracardiac abnormalities. Univariable and multivariable 
logistic regression analyses were performed using SAS 9.1 (SAS, Cary, NC) to identify 
variables predictive of neonatal death prior to cardiac surgery.
Results: We studied 252 consecutive cases of prenatally diagnosed CHD. Of these, 201 
neonates (80%) required cardiac surgery prior to hospital discharge. The remaining 51 
neonates (20%) either died in utero, did not require surgical intervention, or the parents 
decided to provide comfort care. Amongst the 201 neonates who required cardiac surgery, 18 
neonates (9%) died in the hospital prior to planned cardiac surgery and 183 neonates (91%) 
survived to surgery. Univariable and multivariable analyses identified non-Caucasian, non-
African American race (p=0.02), low birth weight (p=0.02), and extracardiac abnormalities 
(p= 0.001) as risk factors for neonatal death prior to planned cardiac surgery.
Conclusion: In our experience with neonates with prenatally diagnosed CHD, race, low 
birth weight, and extracardiac abnormalities were risk factors for neonatal death prior to 
cardiac surgery. Our findings support the importance of discussing co-morbidities as a risk 
factor for neonatal death during prenatal counseling. In addition, our analysis identifies a 
racial health disparity in the outcome of neonates requiring congenital heart surgery.
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1:00 p.m.
1011-126 Large-Scale Screening and Outcome of Complete 
Vascular Rings: A Prospective Study in 186,213 School-
Aged Children
Fong-Lin Chen, Shuping Ge, Chung Shan Medical University Hospital, Taichung, 
Taiwan,ROC, Baylor College of Medicine/Texas Heart Institute, Houston, TX
Background: Complete vascular ring (CVR) has increasingly been recognized as a cause 
of potentially life-threatening tracheoesophageal compression and vascular aneurysm 
rupture. There is little data on the prevalence of CVR and no available means for early 
diagnosis of CVR abnormalities. In this study, we sought to use 2D echocardiography 
(2DE) for screening school aged children to define the prevalence, clinical presentation, 
diagnostic utility of 2DE and outcome of CVR.
Methods: From 2001 to 2004, we screened all 186,213 school-aged children in primary 
and junior high school in central Taiwan by 2DE. CVR was identified in 96 patients 
(51.6/100,000) by 2DE. All patients also underwent barium esophagogram and confirmed 
by spiral CT and/or MRI. The patients with overt clinical symptoms of tracheoesophageal 
compression underwent surgical intervention.
Results: Recurrent bronchopulmonary infections and asthmatic cough were the most common 
symptoms. Right aortic arch (RAA) with Kommerell’s divertiuculum (KD) with left ligamentum 
arteriosum was found to be the most common type of CVR (80.3%). Two-dimensional 
echocardiography had a concordance of 100% compared with CT/MRI and/or surgical findings. 
A total 64 patients had surgical correction with no mortality or significant morbidity.
Conclusions: The incidence of CVR is probably higher than reported in the literature by 
2DE screening. Clinical manifestations do not reliably lead to diagnosis of CVR. Two-
dimensional echocardiography is a useful method for screening and accurate diagnosis 
of CVR. Surgical correction for symptomatic CVR is safe and effective.
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1018-117 Hemodynamic and Angiographic Comparison of 
Patients With Hypoplastic Left Heart Syndrome 
Randomized to Stage 1 Palliation With a Modified 
Blalock-Taussig Shunt or Right Ventricle to Pulmonary 
Artery Conduit
Matthew D. Brown, Raymond T. Fedderly, Stuart Berger, Nancy Ghanayem, James S. 
Tweddell, Andrew N. Pelech, Medical College of Wisconsin, Milwaukee, WI, Children’s 
Hospital of Wisconsin, Milwaukee, WI
Background: Stage 1 palliation for hypoplastic left heart syndrome utilizes either a 
modified right Blalock-Taussig shunt (BT) or a right ventricle to pulmonary artery conduit 
(RV-PA) to provide pulmonary blood flow. We hypothesize that the right-sided BT results 
in preferential right pulmonary artery (RPA) growth and that RV-PA favors left pulmonary 
artery (LPA) growth. This study presents the first reported series of an analysis of this 
question in patients randomized to either BT or RV-PA.
Methods: Eighteen patients with hypoplastic left heart syndrome or its variants were 
randomized at our institution to stage 1 palliation with either BT or RV-PA from January, 
2004 to May, 2005. Fifteen patients survived to a pre- Bidirectional Glenn (BDG) cardiac 
catheterization followed by BDG. We reviewed clinical data, pre-BDG echocardiograms, 
and all standard catheterization data, including any required interventions. Statistical 
analysis was done by Chi-squared tests, ANOVA, and Mann-Whitney tests.
Results: In the 15 surviving patients (8 RV-PA, 7 BT), there were no differences in 
classification of tricuspid insufficiency, right ventricular (RV) dilatation, or RV function by 
either echocardiogram or catheterization. Transcatheter interventions were performed 
only in the RV-PA group. These included balloon dilatation of RV-PA conduit (n=2), 
dilatation of the RPA (n=1), and stenting of the LPA (n=1). Surgical pulmonary artery 
augmentation was performed in 3 RV-PA and 3 BT patients. There were no statistically 
significant differences in RV end-diastolic pressure, diameter of the hilar RPA, hilar 
LPA, proximal RPA, or proximal LPA. The McGoon Ratio, the Nakata Index, and the 
systemic vascular resistance were also not statistically different. Approaching statistical 
significance, the QP/QS ratio was higher in BT (1.0 vs. 0.81, p=0.057) and the pulmonary 
vascular resistance was lower in BT (1.1 vs. 1.7, p=0.068).
Conclusions: This randomized pilot study shows no significant difference in preferential 
pulmonary artery growth; however, differences in QP/QS ratio and pulmonary vascular 
resistance approached statistical significance. A multicenter, prospective, randomized 
study is underway.
9:00 a.m.
1018-118 Sudden Unexpected Death in Children, Cardiac Disease 
and the Use of Psychostimulants: A Population-Based 
Study
Sophie Lessard, Aurore Côté, Charles V. Rohlicek, Montreal Children’s Hospital-McGill 
University Health Centre, Montreal, QC, Canada
Background: It has been suggested that psychostimulants used in the treatment of 
attention deficit hyperactivity disorder (ADHD) increase the risk of sudden unexpected 
death (SUD) in children with a cardiac disorder.
Question: Are psychostimulants used to treat ADHD a risk factor for SUD in children with 
a cardiac disorder?
Methods: In the province of Quebec, every SUD is investigated by a coroner (usually a 
physician). We reviewed data in the coroner’s office concerning all SUD in children aged 
between 3-18 years during the period 1991-2005. SUD was defined as an unanticipated 
non-violent death occurring at most within 24 hours of presentation. Deaths secondary 
to homicide, trauma, intoxication or anaphylaxis were excluded. The number of children 
at risk was estimated from the Statistics Canada database (annual average : 1,380,010). 
A cardiac disorder was defined either as a cardiac malformation, cardiomyopathy, 
myocarditis, a documented arrhythmia or a previous electrographic finding suggesting 
a risk for arrhythmia. We examined every file looking for a reliable medication history or 
post-mortem toxicology screen able to detect psychostimulants.
Results: Between 1991-2005 there were 220 cases of SUD in children and adolescents. 
There was no associated cardiac disorder in 152 cases leaving 68 cases with a cardiac 
disorder. Fourteen of the latter had a previous cardiac diagnosis of which 8 had undergone 
cardiac surgery and 2 were known for Wolfe Parkinson White syndrome (WPW). There 
was no previous cardiac diagnosis in 54 cases (hypertrophic cardiomyopathy=22, 
coronary artery anomalies=9, myocarditis=8, right ventricular arrhytmogenic dysplasia 
=8, and other anomalies=7). Information concerning the use of psychostimulants or a 
high standard toxicology screen was available in 204/220 (93%) cases of SUD. Of these, 
methylphenidate was in use in 3/138 non-cardiac cases and 2/66 cardiac cases (NS, 
Fisher exact test). The latter consisted of 1 case with previously unknown hypertrophic 
cardiomyopathy and 1 with known WPW.
Conclusions: In this contemporary population-based study the use of psychostimulants 
does not appear to have increased the risk of SUD in children with a cardiac disorder.
9:00 a.m.
1018-119 Characteristics of Children Hospitalized With Infective 
Endocarditis
Michael D. Day, Jane Newburger, Kimberlee Gauvreau, Boston Children’s Hospital, 
Boston, MA
Background: Infective Endocarditis (IE) accounts for approximately 1 in 1300 to 1 in 
2000 pediatric admissions per year. Although the reported hospitalization rates for IE 
vary considerably among published series, the frequency of endocarditis among children 
appears to have increased in recent years. The epidemiology of IE has changed in the 
modern era given the marked improvement in survival for patients with complex congenital 
heart disease and expansion of neonatal care.
Methods: Hospital discharge records with an IE diagnosis were identified among children 
< 21 years for the Kids’ Inpatient Databases 2000 and 2003. ICD-9 codes were used to 
search the database for patient diagnoses and procedures. Patient characteristics were 
similar in the two calendar years, so they were combined for further analysis.
Results: In 1588 hospitalizations, the age distribution was bimodal, with peaks in infancy 
and late adolescence (age 17-20 yrs); race/ethnicity were similar to the general population. 
The organism was coded in 508 admissions; Staph aureus was most common (45%), 
followed by Strep viridans (20%). No previous heart disease was coded in 926 admissions; 
associated conditions included neoplasms (9.5%), prematurity (5.8%), connective tissue 
disorders (5.6%), and diabetes mellitus (2.4%). Among those without pre-existing heart 
disease, cardiac surgery was performed in 97 (10.5%) admissions, most commonly aortic 
valve surgery (27%). Pre-existing heart disease was present in 662 admissions (41.7%), 
of which 116 (17.5%) occurred after cardiac surgery. In-hospital mortality occurred in 84 
pts (5.3%). Staph aureus was implicated as the causative organism in 22 of 25 patients 
that died from endocarditis who were not premature infants and did not have pre-existing 
heart disease. Among 44 deaths in pts with pre-existing heart disease, the most common 
diagnosis was tetralogy of Fallot.
Conclusions: In the years 2000 and 2003, IE was a relatively infrequent diagnosis in 
hospitalized children. Its mortality rate is strikingly lower than in adults with IE. Risk factors 
for mortality included premature/neonatal age, underlying heart disease, and Staph 
aureus as the causative organism.
9:00 a.m.
1018-120 Assessment of the Cylex® ImmuKnow™ Cell Function 
Assay in Pediatric Heart Transplant Patients
Joseph Rossano, Susan W. Denfield, E. O’Brian Smith, Jeffrey J. Kim, Jack F. Price, 
John L. Jefferies, Jamie A. Decker, Sarah K. Clunie, Jeffrey A. Towbin, William J. Dreyer, 
Baylor College of Medicine, Houston, TX, Texas Children’s Hospital, Houston, TX
Background: The Cylex® ImmuKnow™ cell function assay (CICFA) is a commercially 
available test of cell-mediated immunity that purportedly identifies patients at risk for 
either acute rejection (AR) or infection. There are very limited data on the utility of this 
test in pediatric heart transplant (HT) patients. The purpose of this study was to test the 
hypothesis that CICFA is a clinically useful test in pediatric HT patients.
Methods: All children undergoing HT at the study center (1989-2006) with CICFA levels 
obtained were reviewed. The association of CICFA levels with episodes of AR and 
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significant infections was determined.
Results: 84 patients (females = 34, 41%) had 367 CICFA levels obtained, median 4.0 [interquartile 
range (IQR) 2.3-6.0] per patient. The median age at transplant was 5.1 (IQR 2.0-12.6) years. 
There were 27 episodes of AR in 17 (20%) patients and 38 infections in 34 (40%) patients. 
CICFA levels were similar among patients with AR at the time of the CICFA measurement 
[median 325 (IQR 163-480) ATP ng/ml] versus patients without AR [median 330 (IQR 227-441) 
ATP ng/ml] (p=0.36). CICFA levels did not discriminate between patients who had AR within 3 
months of CICFA measurement [median 329 (IQR 187-481) ATP ng/ml] versus those who did 
not [median 330 (IQR 227-443) ATP ng/ml] (p=0.54). CICFA levels were similar among patients 
with infections and those without infections within 3 months of CICFA measurement [median 
344 (IQR 211-401) ATP ng/ml] versus [median 330 (IQR 228-456) ATP ng/ml] (p=0.65). Using 
the reported ranges in adult patients, low CICFA levels (≤ 225 ATP ng/ml) were not predictive of 
infection within 3 months (OR 1.2 95%CI 0.50-2.8, p=0.71), and high CICFA levels (≥ 525 ATP 
ng/ml) were not predictive of rejection either at the time of CICFA level (OR 1.1 95%CI 0.37-3.4, 
p=0.85) or within 3 months of CICFA level (OR 1.1 95%CI 0.46-2.6, p=0.82).
Conclusions: The CICFA is not predictive of AR or significant infections in pediatric HT 
patients. Based on the available evidence, this assay cannot be recommended as part of 
the routine management of pediatric HT patients.
9:00 a.m.
1018-121 Computational Simulations Demonstrate Altered 
Biomechanics in Post-operative Aortic Coarctation 
Patients
John F. LaDisa, Jr., Alberto Figueroa, Irene E. Vignon-Clementel, Frandics P. Chan, 
Charles A. Taylor, Jeffrey A. Feinstein, Marquette University, Milwaukee, WI, Stanford 
University & Lucile Packard Children’s Hospital, Palo Alto, CA
Background: Sequelae after successful surgical treatment of aortic coarctation (CoA) 
include hypertension, aneurysms, cardiac dysfunction, stroke and reduced life expectancy. 
These may be explained by abnormal vascular hemodynamics and biomechanics including 
altered wall shear stress (WSS) that can modify gene expression and affect vascular health. 
We used computational fluid dynamics (CFD) to compare blood flow patterns, pressure 
(BP) and WSS in CoA patients with normal subjects (n=5 each). We hypothesize that 
potentially deleterious alterations in blood flow and WSS exist after CoA repair.
Methods: Subject-specific CFD models were constructed from MRI data. Outlet boundary 
conditions that enabled replication of blood flow and BP were applied. CFD simulations 
were performed using a stabilized finite element solver and blood flow, BP and WSS 
were quantified.
Results: Exceptional replication of clinical BP was obtained. Complex, swirling, diastolic 
flow patterns were found in the aorta and branches of both groups. While right-handed 
systolic helical flow was seen in the aortic arch, qualitative differences were found 
between groups. Time-averaged WSS was elevated in the transverse arch and proximal 
descending aortic regions of CoA patients (ex. 43.5 vs 16.7 dyn/cm2, p = 0.0056).
Conclusions: These results suggest persistent hemodynamic alterations, specifically 
in WSS, are present in treated CoA patients and may offer insight into the long term 
morbidity seen even with “successful” treatment.
9:00 a.m.
1018-122 Comparison of Cutting Balloon Dilation to Conventional 
Balloon Dilation for Congenital and Postoperative 
Pulmonary Vein Stenosis
Lynn F. Peng, Doff B. McElhinney, Kathy J. Jenkins, James E. Lock, Children’s Hospital 
Boston, Boston, MA
Background: The optimal method of treating pulmonary vein stenosis (PVS) is unknown. 
This study compares the efficacy of conventional balloon angioplasty (BA) to cutting 
balloon angioplasty (CBA) as an initial intervention for congenital or post operative PVS.
Methods and Results: We compared BA for PVS in previously undilated pulmonary veins 
(PV) from 1999-2003 (first CBA performed) with CBA from 2004-2007. A total of 112 PV 
in 58 pts were studied: 59 PV treated with BA in 34 pts at a median age of 8.5 mos, and 
53 PV treated with CBA in 24 pts at a median age of 7.5 mos. PVS was congenital in 
25%, after repair of anomalous pulmonary venous return in 50%, and after other surgery 
in 25% of pts. There were no differences in age or diagnosis between the 2 groups.
The PV gradient decreased from 11.3±5.6mmHg to 4.9±4.9mmHg (p<0.001) after BA 
versus 19.7±11.4mm to 5.4±3.7mm (p<0.001) after CBA. The decrease in gradient was 
7.4±5.3mmHg for BA compared to 15.4±9.8mmHg for CBA (p<0.001). The diameter of 
the stenotic PV segment increased from 2.6±1.2mm to 4.2± 1.8mm (p<0.001) after BA 
versus 1.9±0.9mm to 3.4±1.2mm (p<0.001) after CBA. The percent change in lumen 
diameter after CBA was 105±90% compared to 70±50% after BA (p<0.02).
There were no procedural deaths or complications requiring surgical repair in either group. 
In the BA group, 1 vessel rupture resulted in hemopericardium requiring drainage, and 1 
patient developed transient hemiparesis. Thirty-one vessels (53%) had reintervention at a 
later catheterization, and 19 (32%) underwent surgical repair. In the CBA group, 4 cardiac 
arrests required resuscitation, and 1 ventricular arrhythmia required cardioversion. Seventeen 
vessels (32%) had catheter reintervention, and 14 (26%) underwent surgical repair.
Conclusions: Both BA and CBA are acutely effective at decreasing gradient and increasing 
lumen size in pts with congenital and post-operative PVS, but reintervention is common 
with both treatments. CBA results in a greater percent change in lumen diameter and in a 
greater reduction in gradient in the setting of a higher starting gradient.
9:00 a.m.
1018-123 Peripheral Vascular Adaptation in Fontan Physiology
Usha S. Krishnan, Indu Taneja, Michael Gewitz, Richard Young, June Glover, Julian 
Stewart, New York Medical College, Valhalla, NY, Maria Fareri Children’s Hospital of 
Westchester, Valhalla, NY
Background:Fontan correction redirects systemic venous return to pulmonary vasculature. 
High systemic venous pressure (Pv) and vascular remodeling sustain effective venous 
return but enhance risk for edema.
Methods:Using venous occlusion plethysmography we investigated the hypothesis that 
vascular capacitance, distensibility and microvascular filtration are reduced, by studying 
8 post Fontan patients (age 10-24yrs m=16.4yrs) and 6 matched controls. Limb venous 
occlusion plethysmography was used to determine the venous volume-pressure relation, 
arterial resistance (Rs), Pv, and filtration relationship. Splanchnic blood flow and venous 
compliance were measured during Valsalva maneuver.
Results: Forearm Rs was similar in both, but calf and splanchnic Rs were twice control. 
Figure 1 depicts leg volume-pressure curves. There is markedly reduced venous capacitance 
in patients, indicating decreased venous distensibility. Figure 2 demonstrates the relation 
between filtration rate and Pv, indicating higher filtration pressures and threshold for edema in 
Fontan patients. Total calf capacitance was lower (3.4 + 0.4 vs 5.6 + 0.4 ml/100ml tissue; p < 
0.03), and Pv higher (14.3 + 0.9 vs 10.5+0.6 mmHg p< 0.02) in Fontan vs control. Splanchnic 
volume change in Fontan indicated significantly reduced splanchnic capacity.Conclusions: 
Reduced venous capacitance and increased filtration thresholds act as adaptive mechanisms 
in maintaining venous return and preventing edema in Fontan circulation.
9:00 a.m.
1018-124 Risk Factors for Graft Loss in Pediatric Cardiac 
Transplantation: Who Should Get a Marginal Donor?
Scott R. Auerbach, Marc E. Richmond, Jonathan M. Chen, Ralph S. Mosca, Jan M. 
Quegabeur, Linda J. Addonizio, Daphne T. Hsu, Jacqueline M. Lamour, Columbia 
University, Morgan Stanley Children’s Hospital of New York, New York, NY
Background: Consideration has been given to the use of marginal donors in heart 
transplantation (Tx) patients (pts) felt to be at higher risk for post-Tx mortality. In order 
to assist in the development of an allocation protocol for the use of marginal donors, 
the impact of reported pre-Tx risk factors on post-Tx mortality in a large single center 
pediatric population was evaluated.
Methods: Chart review of all pts transplanted between 1993-2006 was performed; 
2 pts with a simultaneous kidney Tx were excluded. Graft survival at 1 and 5 yrs was 
compared between pts with and without: Tx age < 1 yr, congenital heart disease (CHD), 
high pulmonary vascular resistance indexed > 6 (PVRI), positive HLA antibodies (PRA+), 
positive cross match (XM+), liver or renal dysfunction, need for intubation, and ventricular 
assist device (VAD). Cox proportionate hazard modeling was performed using predictors 
identified on univariate analysis.
Results: There were 189 primary Tx pts; Tx age was < 1yr in 26 (14%). CHD was present 
in 70 pts (37%); 26 (14%) were post-Fontan. 30 pts (17%) had high PVRI. PRA was + 
in 17 pts (20%) and 8 pts were XM + (12.3%). Liver function was abnormal in 34 pts ( 
18%) and 11 pts had a creatinine > 2mg/dl or required CVVH or dialysis prior to Tx (6%). 
44 pts were intubated prior to Tx (23%) and 32 pts were on VAD (17%). Overall survival 
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was 80% at 1 yr and 66% at 5 yr. Survival was significantly different between pts with 
and without CHD (p=0.02; 87% vs. 70% at 1yr and 67% vs. 63% at 5yr, respectively). 
There was no survival difference between CHD patients with and without a Fontan. Pts 
with renal dysfunction had significantly worse survival at 1 yr (54%) and 5 yrs (45%), 
p=0.002, as did pts requiring intubation (66% at 1 yr and 55% at 5 yrs), p=0.026. Age at 
Tx< 1 yr, high PVRI, PRA+, XM+, liver dysfunction and need for VAD were not associated 
with increased mortality. CHD was associated with a hazard ratio of 1.8 (CI 1.1-2.9) and 
mechanical intubation was associated with a hazard ratio of 1.9 (CI 1.2-3.2).
Conclusions: CHD, renal dysfunction and mechanical ventilation identify pediatric pts at 
higher risk for post-Tx mortality. These risk factors should be considered when developing 
a protocol for the allocation of marginal donors.
9:00 a.m.
1018-125 Changes in Respiratory Syncytial Virus Related 
Hospitalizations and Prevention in Infants With Cardiac 
Anomalies
Christian Hampp, Almut G. Winterstein, Arwa Saidi, Miriam Schauff, University of 
Florida, Gainesville, FL
Background: The RSV prevention guideline was updated in 2003 to include high-risk infants 
with cardiac anomalies in the recommendation for immunization with palivizumab.
Methods: We analyzed claims data from Florida Medicaid for October through February 
of the two consecutive RSV seasons before (2001-03) and after guideline implementation 
(2003-05). Hospitalization (HR) and immunization (IR) rates were calculated for each 
month including all infants who were eligible for Medicaid and not hospitalized for at 
least 30 days before the respective month. High risk-infants with cardiac anomalies were 
defined as (I): less than 24 months old with significant cyanotic or acyanotic congenital 
heart disease (CHD). Subsets of (I) are infants less than 12 months old, additionally with 
(II) congestive heart failure (CHF), (III) pulmonary hypertension or (IV) cyanotic heart 
disease. Immunization was defined as at least one claim for palivizumab in the respective 
month; RSV-related hospitalization included inpatient claims with at least 1 ICD-9 code: 
V04.82, 079.6, 466.11 or 480.1.
Results: For indication I (n= 32,573 patient months), IR increased from 15.2% to 20.7% 
(p<0.001) while HR showed an insignificant change from 0.7% to 0.6% (p=0.193). For 
indication II (n=1,325), IR increased from 21.6% to 55.4% (p<0.001) with a corresponding 
decrease in HR from 2.0% to 1.0% (p=0.181). IR in indication III (n=688) increased from 
20.1% to 32.3% (p<0.001), while HR dropped from 2.2% to 0.7% (p=0.169). Finally, for 
indication IV (n=10,316), IR increased from 9.3% to 15.5% (p<0.001) but HR remained 
virtually the same (0.7% to 0.6%, p=0.443).
Conclusion: Overall, palivizumab utilization was and remained low despite the strength of 
evidence for effectiveness among children with CHD. We observed a more substantial increase 
in utilization for the subgroup of children with CHF or pulmonary hypertension in combination 
with CHD. Increase in utilization was associated with a decrease in hospitalizations, which, 
however, did not reach statistical significance as a result of limited power.
9:00 a.m.
1018-126 Congenital Vascular Ring Abnormalities Are Associated 
with Reversible Lower Intellectual Performance in 
School-aged Children: Potential Impact of Early 
Diagnosis and Intervention
Fong-Lin Chen, Jing-Jong Liu, Shuping Ge, Chung Shan Medical University Hospital, 
Taichung, Taiwan,ROC, Baylor College of Medicine/Texas Heart Institute, Houston, TX
The indication for surgery for congenital vascular ring (VR) abnormalities relies on 
symptoms of tracheal and esophageal compression. However, the effect of VR on 
development and intelligence in school-aged children is unknown.
Methods: A total of 49 school-aged children (age: 10.1±3.3 years) with newly diagnosed 
VR were prospectively recruited. In this cohort, 32 had complete VR and 17 partial VR. For 
comparison, 20 normal controls (age: 9.7±1.4 years) were also enrolled. The Wechsler 
Intelligence Scale for Children-III (WISC-III) was used to assess the intellectual abilities.
Results: Compared with normal controls, children with VR showed significantly lower 
scores in full-scale IQ (PSIQ) (p<0.001), verbal IQ (VIQ) (p<0.001) and performance IQ 
(PIQ) (p<0.001)(Figure 1). They also demonstrated lower performances in 3 other indices, 
including verbal comprehensive index (VCI) (P<0.001), perceptual organizational index 
(POI) (P<0.001), and processing speed index (PSI) (p=0.004). All of the above tests in 
WISC-III were significantly improved after surgical treatment (P 1 year).
Conclusions: This study demonstrated that school-aged children with undiagnosed/
untreated VR have lower intellectual capabilities than normals, which are reversible 
after surgical intervention. In addition to clinical symptoms of airway and esophageal 
obstruction, our study suggests early diagnosis and intervention of VR are warranted for 
optical intellectual performance in school. 
9:00 a.m.
1018-136 Non - Invasive Pulsed Cavitations Ultrasound Therapy 
(Histotripsy) for the Creation of Controlled Atrial Septal 
Defects - In Vivo study
Achi Ludomirsky, Zhen Xu, Brian J. Fowkes, Charles A. Cain, Washington University, 
St.Louis, MO, University of Michigan, Ann Arbor, MI
Background: Hypoplastic Left Heart Syndrome with Intact Atrial Septum carries a dismal 
outcome due to atrial and pulmonary venous hypertension. We developed a non-invasive 
ultrasound procedure to create atrial septal defect. Our previous in vitro study has shown 
that mechanical tissue fractionation can be achieved using successive high intensity 
ultrasound pulses through cavitation (“Histotripsy”). The goals of this study were 1. To 
evaluate the feasibility of Histotripsy to non invasively create an atrial communication in the 
in vivo settings and 2. To assess the integrity of the surrounding tissue folowing procedure.
Methods: Ultrasound pulses were delivered to the atrial septum in an open chest model in 
five canines. Ultrasound/Doppler imaging were used for targeting, real-time monitoring and 
to determine the onset and the existence of atrial septal communication. The therapeutic 
transducer focus on the ultrasound imaging was located by producing a hyperechoic zone 
in a water tank prior to targeting the atrial septum. Ultrasound pulses (6µs duration) at 
a peak negative pressure of 15 MPa and a pulse repetition frequency of 5 kHz were 
generated by a high power 1MHz focused transducer until atrial communication was 
achieved. The histology of the atrial septa were reviewed folowing H&E staining.
Results: A complete perforation of the atrial septa was achieved in 4/5 canine hearts within 
6-8 min (Mean 6.3min) of exposure. After treatment, Doppler imaging demonstrated blood 
flow between the two atria. Histology showed 2-5 mm diameter complete perforations of 
the atrial septum in 4/5. One atrial septal lesion demonstrated a residual thin membrane 
without clear perforation. All lesions showed sharply demarcated boundaries with normal 
atrial septal cellular architecture of the surrounding tissue.
Conclusions: Histotripsy successfully create controlled perforations of atrial septum using 
non invasive ultrasound waves in the in vivo settings. The integrity of the surrounding 
tissue remained intact. Histotripsy may be used in the future as non-invasive technique for 
cardiac application including fetal and electrophysiological interventions.
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1:00 p.m.
1025-117 Postoperative mannose binding lectin expression 
correlates with outcomes after infant cardiac surgery
Mark A. Scheurer, Catherine A. Allan, Gregory L. Stahl, Benjamin J. Guikema, Charles 
Psoinos, Pedro J. del Nido, Frank X. McGowan, Jr., Children’s Hospital Boston, Boston, 
MA, Brigham and Women’s Hospital, Boston, MA
Background: Mannose binding lectin (MBL) has several key roles in innate immunity, 
including complement activation. We have previously shown that MBL causes 
complement-dependent ischemia-reperfusion injury in animal models. Its pattern of 
expression and effect in infants undergoing to cardiopulmonary bypass (CPB) for cardiac 
surgery is not known.
Methods: In 160 infants undergoing definitive and palliative cardiac surgery with CPB, 
plasma concentrations of MBL and cytokines were measured pre-CPB, immediately 
post-CPB, and at 6, 12, and 24 hr post-CPB. The relationships between MBL and other 
variables were assessed using Spearman correlation coefficients.
Results: Median age was 81 days (0 - 328), and weight was 4.2 kg (2.1 - 8.1). MBL 
(mcg/ml, mean ± SD) decreased post-CPB (1.7 ± 1.8) vs. pre-CPB (2.4 ± 2.5), increased 
at 12 (2.2 ± 2.0), and then decreased at 24 hrs (1.8 ± 1.7) (p<0.001). Increased MBL 
was associated with decreased lactate post CPB, 24 hr PRISM III scores, duration of 
ventilation, and length of ICU and hospital stays, and increased production of the anti-
inflammatory cytokines IL-4 and IL-12 (Table 1).
Conclusions: MBL expression after CBP in infants correlates with improved postoperative 
outcome and increased anti-inflammatory cytokines, suggesting an immunomodulatory 
role. This finding differs from the deleterious effects of MBL demonstrated in animal 
models of ischemia-reperfusion injury. Further examination of MBL regulation and effect 
are warranted in infants undergoing CPB.
Table 1. Correlations of 24hr MBL with postoperative cytokines and outcome variables
1 2 h r 
Il-4
1 2 h r 
Il-12
2 4 h r 
lactate
24hr PRISM 
III score
Duration of 
ventilation
Length of 
ICU stay
Length of 
hospital stay
r 0.37 0.45 -0.31 -0.19 -0.20 -0.20 -0.19
p -
value <0.01 <0.01 <0.01 0.03 0.01 0.02 0.02
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1:00 p.m.
1025-118 Surgical Outcomes for Patients Undergoing Anatomic 
Repair of Congenitally Corrected Transposition of the 
Great Arteries
Michael G. Gaies, Caren S. Goldberg, Edward L. Bove, University of Michigan, Ann Arbor, MI
Background: The optimal surgical approach to children with congenitally corrected 
transposition of the great arteries (CCTGA) remains controversial. We aimed to measure 
early surgical outcomes in children undergoing anatomic repair and to identify risk factors 
influencing these outcomes.
Methods: Medical record review was performed on all patients who underwent anatomic 
repair of CCTGA from 1993 to 2007. Outcomes measured included transplant-free 
hospital survival, major in-hospital morbidity (need for ECMO or dialysis, and neurologic 
events), and complete heart block. Demographic, anatomic and physiologic factors were 
evaluated for association with outcomes using Fishers Exact Test or Chi Square for 
categorical variables and Wilcoxin Rank Sum for ordinal non-parametric variables.
Results: Fifty seven patients were included; 30 had a Senning-Arterial Switch operation (S-
ASO) and 27 had an atrial switch with Rastelli (S-R). Survival to discharge was 93 and 78% 
for the S-ASO and S-R groups, respectively. Survivors had morbidity rates of 10% in the 
S-ASO group, and 33% in the S-R group. The overall median operative age was 16 months 
(range 1-120). There was no association with outcome in either group for age, atrial-apical 
discordance, an Ebsteinoid tricuspid valve, degree of tricuspid regurgitation (TR), right 
ventricular function, left ventricular (LV) function, or LV pressure. Moderate or severe TR was 
present in 16 S-ASO patients, with only one mortality and two morbidities among survivors. 
There were no mortalities and only one morbidity in 8 S-ASO patients with mild to severe 
subvalvar pulmonary stenosis. Four patients in the S-ASO group had mild to moderate LV 
dysfunction; all survived and only one had a significant morbidity. Within the S-R sub-group, 
only operative time was associated with mortality (p=0.048). Surgical enlargement of a 
ventricular septal defect predicted the development of heart block (p=0.0008).
Conclusions: The S-ASO procedure can be performed successfully in children with TR, LV 
outflow obstruction, and mild to moderate LV dysfunction. Multicenter studies are required 
to identify which factors increase risks for patients undergoing the S-R procedure.
1:00 p.m.
1025-119 Impact Of Surgical Closure Of Ventricular Septal 
Defects With Prolapsed Aortic Valve On Aortic Cusp 
Deformity Indices Assessed By Two-Dimensional 
Echocardiography
Martin NL Wong, Prashant Joshi, Kui Hian Sim, Sarawak General Hospital, Kuching, 
Malaysia
Background: Aortic valve prolapse (AVP) is a frequent complication among Oriental with 
subaortic ventricular septal defects (VSD), resulting in deformity of aortic cusps and aortic 
regurgitation (AR). Early surgical closure of VSD is advocated to retard the progression of 
AR but it is not known if it can restore normal morphology of the deformed aortic cusps.
Methods: Twenty eight patients (mean age 10.3 ± 5.2 years) with VSD and AVP 
underwent surgical closure of VSD. Right coronary cusp (R/L) and non-coronary cusp 
(N/L) imbalance indices were obtained on two-dimensional echocardiography before 
and after surgery. Cases with gross aneurysm or rupture of sinus of Valsalva requiring 
additional aortic valve surgery were excluded.
Results: VSD was subpulmonic in 35.7%, perimembranous in 42.9% and muscular 
outlet in 21.4%. All patients had prolapse of right coronary cusp. Half of them also had 
concomitant non-coronary cusp prolapse. AR was absent in 10.7%, trivial in 32.1%, mild 
in 28.6% and moderate in 28.6%. Following surgery, there were significant improvement 
in both R/L and N/L indices compared to pre-operative values (from 1.36 ± 0.16 to 1.18 
± 0.17, p < 0.001 and from 1.21 ± 0.20 to 1.10 ± 0.16, p = 0.002 respectively). AR also 
improved in half of the patients.
Conclusion: Surgical closure of VSD reduces severity of aortic cusp deformity and 
restores its normal morphology in patients with AVP. Hence it may have favorable impact 
on the long term outcomes. 
1:00 p.m.
1025-120 Low Cerebral Near Infrared Spectroscopy Following the 
Norwood Procedure Predicts Adverse Outcome
Heather M. Phelps, William T. Mahle, Janet M. Simsic, Paul M. Kirshbom, Kirk R. Kanter, 
Kevin O. Maher, Emory University, Atlanta, GA, Children’s Healthcare of Atlanta, Atlanta, GA
Background: Cerebral Near Infrared Spectroscopy (cNIRS) provides a non-invasive 
means to evaluate cerebral perfusion, with many centers routinely monitoring cNIRS 
following surgery for congenital heart disease. Prior studies have demonstrated that 
decreased systemic venous saturation can predict adverse outcome following the 
Norwood procedure. We sought to determine whether cNIRS data could predict risk of 
adverse outcome in this patient population.
Methods: We reviewed the initial 48 hours of post-operative hemodynamic data for 
the most recent 50 patients with HLHS at our institution who underwent the Norwood 
Procedure (BT shunt n=9 , Sano conduit n=41). cNIRS data were analyzed for association 
with subsequent adverse outcome. Adverse outcome was defined as ICU length of stay 
greater than 30 days, need for ECMO, and/or hospital death.
Results: There were 11 adverse outcomes among the 50 subjects. The mean cNIRS for 
the entire cohort at 1 hr, 4 hrs, and 48 hrs after surgery were 51%±7.5, 50%±9.4, and 
59%±8.1, respectively. Low cNIRS (mean < 55%) was associated with an increased risk 
of adverse outcome, odds ratio 11.9, (95% CI 2.5 - 55.8), p= 0.003. There was a trend 
toward lower cNIRS in the patients with BT shunts as compared to those with Sano 
conduits (mean cNIRS 54.6% and 60.0% respectively, p=0.054). Right and left-sided 
cNIRS probes yielded similar results; the mean Δ from right to left was -1.2%± 5.0. There 
was no evidence of lower right-sided cNIRS in the BT shunt patients as compared to the 
Sano shunt patients.
Conclusions: Low cNIRS measurements in the first 48 hours following the Norwood 
procedure are associated with subsequent adverse outcomes. cNIRS can serve as a 
valuable monitoring tool to identify patients who are at high risk for adverse outcome and 
should be used routinely following the Norwood procedure.
1:00 p.m.
1025-121 Three-Dimensional Fly-Through Post-Processing 
of Magnetic Resonance Images Identifies Coronary 
Ostial Stenosis in Patients With Anomalous Origin of a 
Coronary Artery
Matthew A. Harris, Paul M. Weinberg, Timothy Y. Liu, Michael T. Cosulich, Thomas L. 
Spray, Mark A. Fogel, The Children’s Hospital of Philadelphia, Philadelphia, PA
Background: Anomalous coronary artery origin - both coronaries from the same sinus 
of valsalva - has been identified as a cause of sudden death. Coronary arteries arising 
from the contralateral sinus often have a tangential origin from the aorta with an elliptical 
ostium resulting in ostial stenosis. MRI identifies the sinus of origin of each coronary 
artery. Yet, distinguishing single versus separate ostia from the same sinus, and ostial 
stenosis is challenging with 2-dimensional imaging.
Methods: We retrospectively reviewed 6 pediatric cardiac MRI 3-dimensional data sets of 
pts with anomalous left (ALCA) (n=2) or anomalous right (ARCA) (n=4) coronary arteries. 
The data were analyzed with “Fly-Through” software allowing one to view the dataset as 
if within the vessel.
Results: Of 4 pts with ALCA, 2 have a single right coronary artery without ostial stenosis. 
Of the remaining 2 pts, 1 had an elliptical ostial opening of the left coronary artery (Fig 
A) suggesting stenosis, (compared to normal right ostium (Fig B)) and the other had 2 
adjacent ostia without evidence of ostial stenosis. Both pts with ARCA had 2 separate 
ostia: 1 was identified with ostial stenosis related to a tangential origin. Three of the 6 
pts had their imaging findings confirmed at surgery (Fig C), and the remainder did not 
undergo surgical intervention.
Conclusions: “Fly-Through” technique non-invasively identifies ostial stenosis associated with 
ALCA and ARCA. This data may become important in stratifying a pt’s risk for sudden death.
1:00 p.m.
1025-122 The Ross-Konno Procedure: Intermediate Term Clinical 
and Echocardiographic Follow-up
Bahaa M. Fadel, Bahaaldin Alsoufi, Sara S. Al-Dekhyl, Ziad Bulbul, Ahmad Sallehuddin, 
Zuhair Al-Halees, King Faisal Specialist Hospital, Riyadh, Saudi Arabia
Background: The Ross-Konno procedure is intended for the surgical treatment of patients 
with aortic valve disease associated with left ventricular outflow tract obstruction (LVOTO) 
and/or annular hypoplasia. We aim to assess clinical outcomes and performance of the 
autograft and pulmonary homograft following this procedure.
Methods: From 1994-2005, 398 patients underwent a Ross procedure at our institution. 
Our study cohort includes 37 patients (9%) who underwent a Ross-Konno procedure. 
Median age was 5.5 years (12 days-17 years, infants = 7) with a mean follow-up of 58 ± 35 
months. Twenty nine patients (78%) had previous surgical or percutaneous interventions 
and 12 (32%) had a concomitant procedure at the time of the Ross-Konno.
Results: There was 1 operative (3%) and 2 late deaths (5%) at 6 and 12-month post-
operatively. At follow-up, no patient had residual or recurrent LVOTO or autograft stenosis. 
Four (12%) and 1 patient (3%) developed 2+ and 3+ autograft insufficiency, respectively. 
There was no significant autograft annular dilatation from early to late post-operative 
follow-up (Z value 1.34 ± 1.79 vs. 1.88 ± 1.16; p = 0.06), however root dilatation was 
observed (Z value 1.58 ± 1.46 vs. 2.42 ± 1.34; p = 0.002). Significant homograft dysfunction 
developed in 17 patients (46%) mainly as insufficiency. During follow-up, 6 patients (16%) 
required reoperations on the pulmonary homograft (n = 5), mitral valve (n = 2), tricuspid 
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valve (n = 2), and ascending aorta (n = 1). Two additional patients (5%) underwent balloon 
dilatation of stenotic homograft. No patient required reoperation on the autograft. Five and 
10-year freedom from homograft reoperation was 81% and 61%, respectively. There were 
no thromboembolic or infectious complications. All survivors were in NYHA I/II.
Conclusions: The Ross-Konno procedure is associated with an acceptable mortality 
rate, optimal relief of LVOTO, satisfactory durability of the autograft and lack of excessive 
dilatation of the neoaortic annulus. However the neoaortic root undergoes dilatation 
beyond somatic growth and few patients experience more than mild autograft insufficiency. 
The pulmonary homograft is a major source of late morbidity and reoperation.
1:00 p.m.
1025-123 Short Axis Rotation and Circumferential Strain in 
Patients With Single Ventricle
Ling Hui, Andrew Hoyer, Mary S. Minette, David J. Sahn, Oregon Health & Science 
University, Portland, OR
Background: Rotation and torsion are essential components of left ventricular (LV) 
function. Near the apex, the normal LV rotates counterclockwise (CCW) in systole and 
rapidly rotates clockwise (CW) in early diastole. Single ventricles (SV) lack the spiral 
architecture which is essential for LV twisting
Methods: We examined 15 patients with double inlet SV or SV with absent right AV 
connection (post Fontan, ages 6-21 yrs) and 11 children and adults (ages 9-25 yrs) 
with normal echos, using a GE Vivid 7 system at 7-10 MHz. Short axis 2D images 
were analyzed by speckle tracking 2D strain software that calculates rotation and 
circumferential strain.
Results: Mean circumferential strains (for all segments) were -12.5% ± 2.4% for normal 
children and -5.1% ± 1.4% for patients with SV. CCW rotation in short axis views near the 
apex was -7.6º ± 1.5º for normal children and -2.1º ± 0.6º for patients with SV (p<0.01). 
The normal children had a correlation between circumferential rotation and strain (r=0.84), 
but SV patients had markedly reduced twisting and twist and circumferential strain were 
not correlated.
Conclusions: While SV patients had some preservation of circumferential strain, they 
had markedly reduced individual segmental rotation. There was a loss of synchrony for 
segmental twist and also a loss of correlation between circumferential strain and rotational 
components of function.
1:00 p.m.
1025-124 Gender And Outcome In Congenital Heart Disease
Carianne L. Verheugt, Cuno S.P.M. Uiterwaal, Enno T. van der Velde, Folkert J. 
Meijboom, Petronella G. Pieper, Hubert W. Vliegen, Arie P.J. van Dijk, Berto J. Bouma, 
Diederick E. Grobbee, Barbara J.M. Mulder, Academic Medical Center, Amsterdam, The 
Netherlands, University Medical Center Utrecht, Utrecht, The Netherlands
Background: Gender differences in prevalence of congenital heart disease at birth have 
been widely documented. The objective of this study was to determine whether gender 
influences the risk of complications in adult patients with congenital heart disease.
Methods: From the CONCOR registry database (van der Velde, Eur J Epidemiol. 
2005:20:549-57) 7414 patients were identified. Logistic regression was used with 
complication (yes/no) as outcome and gender as predictor. All analyses were adjusted 
for age and for the most frequent underlying congenital heart defects per complication. 
Results are expressed as relative risks (RR) and 95% confidence intervals (CI). 
Confidence intervals not including 1 are considered statistically significant.
Results: The figure shows that, compared to men, women had a 33% higher risk of 
pulmonary hypertension (RR=1.33, 95%CI 1.07-1.65, p=0.01), a 33% lower risk of aortic 
complications (RR=0.67, 95%CI 0.50-0.90, p=0.007), a 47% lower risk of endocarditis 
(RR=0.53, 95%CI 0.40-0.70, p<0.001), and a 55% lower risk of implantable cardioverter 
defibrillator (ICD) implant (RR=0.45, 95%CI 0.26-0.80, p=0.006). Further, women had a 
borderline statistically significant 12% lower risk of arrhythmias (RR=0.88, 95%CI 0.77-
1.02, p=0.08).
Conclusions: The risk of several major cardiac complications in adult patients with 
congenital heart disease is determined by gender. 
1:00 p.m.
1025-125 How Useful Is the 12-Lead ECG for Detection and 
Localization of Atrial Septal Defects? A Study in 326 
Adolescent and Adult Patients
Sara S. Al-Dekhyl, Taghreed M. Nadra, Ghassan Siblini, Bahaa M. Fadel, King Faisal 
Specialist Hospital, Riyadh, Saudi Arabia
Background: Recent data have challenged long held beliefs regarding the usefulness of 
ECG for detection and localization of atrial septal defects (ASD). We set to determine its 
value in the modern era.
Methods: We reviewed pre-closure ECG of 326 patients with isolated ASD (median age 
27, range 14-84 years) from 1984-2007. All ECG were analyzed by 2 observers blinded to 
defect location. The presence and location of ASD were established by echocardiography 
and/or at closure with requirement for right ventricular volume and/or pressure overload.
Results: The rate of secundum, venosus and primum defect was 86%, 9% and 5%, 
respectively. An abnormal ECG was found in 84% of patients. Main abnormalities 
include incomplete right bundle branch block (IRBBB) (58%), abnormal QRS axis (53%), 
prolonged QRS interval ≥ 100 msec (47%), 1º degree AV block (14%), inverted P wave 
in ≥ 1 inferior lead (13%), RBBB (10%) and atrial fibrillation (4%). No patient with primum 
had a right QRS axis compared to 44% of secundum and 68% of venosus defects. A left 
QRS axis was found in 50%, 3% and 4% of primum, secundum and venosus defects. 
Classical ECG criteria for secundum ASD (IRBBB with right QRS axis) were present 
in 32% of secundum cases. Criteria for primum ASD (IRBBB with left QRS axis) were 
noted in 31% of primum cases. Similarly, inverted P wave in ≥ 1 inferior lead was found 
in 43% of venosus cases. When present, these criteria correctly classified secundum, 
primum and venosus defects in 87%, 50% and 30% of patients, respectively. Following 
the same criteria, ECG would have incorrectly localized the ASD in 14% and provided 
no characteristic findings to allow localization in an additional 50% of cases. Of interest, 
63% of patients with inverted P wave in ≥ 1 inferior lead and 50% with left QRS axis had 
secundum defects.
Conclusions: The ECG is abnormal in the majority of adolescents and adults with ASD 
and thus may serve as a screening tool. Criteria such as P wave inversion or left QRS 
axis do not allow classify a defect as venosus or primum, respectively. An IRBBB with 
right QRS axis excludes a primum ASD, however this combination is present in a minority 
of patients with secundum ASD to add much value to localizing this defect beyond its 
expected incidence.
1:00 p.m.
1025-126 Pulmonary Vein Antrum Isolation for the Treatment 
of Atrial Fibrillation in Adults With Congenital Heart 
Disease
Femi Philip, Connor D. Barrett, Oussama Wazni, Andrea Natale, Richard Krasuski, 
Cleveland Clinic Foundation, Cleveland, OH
Background: Atrial fibrillation (AF) is a common arrhythmia in adults with congenital 
heart disease (ACHD). Long-term antiarrythmic therapy in these patients has significant 
shortcomings. The safety and efficacy of pulmonary vein antrum isolation (PVAI) for the 
treatment of AF in ACHD is presently unknown.
Methods: We reviewed a prospective cohort of 4315 patients who underwent a PVAI for 
drug refractory AF and identified patients ≥ 18 yrs of age with congenital heart disease 
(single ventricle physiology, tetrology of fallot, coarctation of the aorta, ventricular septal 
defects, atrial septal defects (ASD) and cardiomyopathy resulting from anolomous origin 
of the left coronary artery from the pulmonary artery). All patients were closely followed 
with scheduled clinic visits, trans-telephonic and 12-lead electrocardiography, and serial 
chest computerized tomography. Success was defined as freedom from AF two months 
after PVAI in the absence antiarrythmic therapy (AAT) until the end of follow-up.
Results: 32 patients (0.7% of the cohort) with a mean age 50 ± 12.5 yrs (19 male) with 
ACHD had PVAI for AF over an 8 year period (1999-2007). In one patient, transeptal 
puncture was not successful due to prosthetic material. The most common ACHD was 
ASD (59%). The mean duration of follow-up was 17 months. There was a 50% success 
rate after the first PVAI procedure. A further eight patients had a second PVAI, which was 
successful in three. A further two patients were arrhythmia free while maintained on AAT. 
The cumulative complication rate was 11% with access site vascular complications (none 
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requiring surgical intervention) being the most common (6%), followed by pulmonary vein 
stenosis (4%). There were no strokes and only one presumed embolic event.
Conclusion: PVAI appears to be an attractive treatment modality in drug refractory AF in 
patients with ACHD, albeit with a slightly lower success rate to previously published data 
in the general population.
ACC.ORAL CONTRIBUTIONS
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2:30 p.m.
808-3 Atrial Fibrillation Doubles Mortality in Adults With 
Congenital Heart Disease: A Population Based Study 
From 1983 to 2005
Judith Bouchardy, Judith Therrien, Louise Pilote, Raluca Ionescu-Ittu, Giuseppe 
Martucci, Ariane J. Marelli, McGill Adult Unit for Congenital Heart Disease Excellence 
(MAUDE Unit), Montreal, QC, Canada, McGill University Health Centre Research 
Institute, Montreal, QC, Canada
Background: Although ventricular arrhythmias have been extensively studied in adults 
with congenital heart disease (ACHD), data examining the impact of atrial arrhythmias 
(AA) on outcomes of ACHD patients are lacking. Our objectives were to determine 
prevalence of AA in an ACHD population and to compare mortality and hospitalization 
rates in those with and without AA.
Methods: The study population consisted of all patients > 18 years in year 2005. A 
congenital heart disease diagnosis was assigned to each patient using ICD-9 diagnostic 
codes in administrative databases of Quebec from 1983 to 2005. Patients with AA are 
those diagnosed with an ICD-9 code for atrial fibrillation or intra-atrial-reentry-tachycardia 
over the 18 year study period. Prevalence of AA was measured in year 2005 as AA cases 
per 1,000 ACHD patients as well as in lesion and age-specific groups. We report the crude 
rates for mortality (deaths/1,000 population) and hospitalization (hospitalization days / 
1000 person-days) in year 2005 in those with and without AA and the corresponding rate 
ratios (RR) after direct standardization for age group and CHD severity.
Results: In a population of 38,428 ACHD patients, 5,812 (150/1,000 ACHD population) 
had AA. Prevalence of AA varied from 49/1,000 in patients with ventricular septal defect to 
274/1,000 in those with transposition of the great arteries, and from 28/1000 in age group 
18-35 years to 394/1,000 in those aged > 65 years. Crude mortality rate was 55 /1,000 
in the AA group versus 9/1,000 in the non AA, corresponding to a standardized RR of 
2.14 (95% confidence interval 1.81-2.52). Crude hospitalization rate was 5.06 days /1,000 
person-days in the AA group versus 0.81 /1,000 in the non AA population, corresponding 
to a standardized RR of 3.16 (95% confidence interval 3.06-3.26).
Conclusion: In this large ACHD population study, 15% of patients had AA. The presence 
of atrial arrhythmias in ACHD patients triples hospitalization rates and doubles mortality.
2:45 p.m.
808-4 Measurements of the Systemic Right Ventricle by 
means of Cardiovascular Magnetic Resonance 
analysis: the role of Trabeculations and Papillary 
Muscles
Michiel M. Winter, Flip J.P. Bernink, Berto J. Bouma, Maarten Groenink, Arie P.J. van 
Dijk, Barbara J.M. Mulder, Academic Medical Center, Amsterdam, The Netherlands, 
University Medical Center Nijmegen, Nijmegen, The Netherlands
Background: Evaluation of left and right ventricular volume and function can accurately 
be performed by means of Cine Cardiovascular Magnetic Resonance Imaging (CMR). 
However, in patients with a systemic right ventricle (RV), hypertrabeculation and the 
excess of papillary muscles may considerably influence assessed volumes and ejection-
fraction, and therewith clinical decision making. Currently, trabeculations and papillary 
muscle volumes are generally neglected and considered part of the ventricular cavity. 
The present study was to evaluate the impact of trabeculations and papillary muscles on 
measurements of systemic RV volumes and function by means of CMR.
Methods: Twenty four patients (62% male, 23-69 years old) with a systemic RV (12 
with a congenitally corrected transposition of the great arteries and 12 with an atrially 
switched transposition of the great arteries) were included in this study. Cine CMR was 
used to assess systemic right ventricular volumes and function, using two different 
analysis protocols. First, measurements were performed using the standard protocol of 
considering trabeculations and papillary muscles part the systemic RV cavity, and then 
again by subtracting trabeculations and papillary muscles from the ventricular cavity. The 
two methods were compared to examine whether there was a systematic difference.
Results: Significant differences between the two methods were found for all measures. 
Subtracting trabeculations and papillary muscles from the ventricular cavity resulted in 
lower values for systemic RV end-diastolic volume with a mean difference of 25.8 ± 11.6 
ml (p<0.001) and for systemic RV end-systolic volume with a mean difference of 30.4 ± 
12.8 ml (p<0.001). Values for systemic RV ejection fraction were significantly higher with 
a mean difference of 8.1 ± 4.6% (p<0.001).
Conclusion: Different CMR analysis protocols lead to substantially and systematically 
different outcomes in systemic RV volumes and function. Therefore, standardized and 
transparent analysis protocols are mandatory for this patient group, and analysis protocol 
should be taken into consideration before making clinical decisions.
3:00 p.m.
808-5 Ebstein Anomaly and Left Ventricular Dysfunction: 
Effect of Tricuspid Valve Operation
Morgan L. Brown, Joseph A. Dearani, Gordon K. Danielson, Frank Cetta, Heidi M. 
Connolly, Carole A. Warnes, Zhuo Li, David O. Hodge, David J. Driscoll, Mayo Clinic, 
Rochester, MN
Background: Our objective was to determine the effect of tricuspid valve repair/
replacement on left ventricular function for patients with Ebstein anomaly and reduced 
left ventricular function.
Methods: From April 1, 1972 to January 1, 2006, 539 patients with Ebstein’s anomaly had 
604 cardiac operations at the Mayo Clinic. Left ventricular (LV) function was determined 
by echocardiography.
Results: The early mortality for the 539 patients was 6% and 20 year overall survival 
was 71%. Of the 495 patients with preoperative echocardiographic assessment of LV 
function, 5 had moderate-severe and 13 had severe LV dysfunction. The tricuspid valve 
was repaired in 4 patients and replaced in 14 patients. There were 2 early deaths (11%). 
For the 18 cases with greater than moderate preoperative LV dysfunction, dismissal or 
pre mortem echocardiography demonstrated postoperative LV function as normal (n=9), 
mildly reduced (n=2), moderately reduced (n=4), moderate-severely reduced (n=1), 
severely reduced (n=1) and unknown (n=1). The 30- day, 1- year, and 5- year survivals 
were 88%, 88%, and 69% respectively. In 337 patients who had TV replacement, a 
multivariate model predicted preoperative LV dysfunction was associated with reduced 
survival and with lower survival free from reoperation in patients (p<0.05). In 182 patients 
with TV repair, preoperative LV dysfunction was a univariate predictor of reduced survival 
and a lower survival free of reoperation (p<0.05).
Conclusions: Left ventricular dysfunction is rare but occurs in Ebstein anomaly. LV 
dysfunction is a risk factor for increased mortality and need for late reoperation in some 
patients with Ebstein anomaly. While early mortality is greater than in patients without LV 
dysfunction, the late results are favorable. Of the surviving patients, all but one patient 
had improved LV function after tricuspid valve repair/replacement. Decreasing LV function 
should be an indication to promptly restore tricuspid valve competence rather than a 
contraindication to tricuspid valve surgery.
3:15 p.m.
808-6 Sildenafil Improves Hemodynamic Response to 
Exercise and Exercise Capacity in Fontan Patients
Alessandro Giardini, Anna Balducci, Andrea Donti, Gaetano Gargiulo, Marco Bonvicini, 
Fernando M. Picchio, Pediatric Cardiology and Adult Congenital Unit, University of 
Bologna, Bologna, Italy
Background: Fontan patients have reduced exercise capacity and reduced cardiac 
output response to exercise. Increased pulmonary vascular resistance, limited ventricular 
preload reserve, and increased afterload contribute to exercise intolerance. We sought 
to assess the effects of sildenafil on exercise capacity and hemodynamic response to 
exercise in Fontan patients.
Methods: We prospectively studied 27 patients with Fontan circulation (age 22.8±4.9 
years). All patients underwent a baseline exercise test with non-invasive measurement of 
cardiac index and pulmonary blood flow (PBF) index, and peak exercise oxygen uptake 
(VO2). After the baseline test, patients were randomized to receive a single oral dose 
of sildenafil (n=18) or no treatment (control group, n=9). After 1 hour of rest all patients 
performed a second exercise test.
Results: Cardiac index and PBF index increased at rest and at all exercise stages in 
the sildenafil group but not in control subjects (p between 0.006 and <0.0001 for all 
comparisons of sildenafil vs. control group). Peak VO2 increased in the sildenafil group 
(+9.4±5.2%, p<0.0001) but not in the control group (+0.3±4.1%, p=0.91). Systolic and 
diastolic arterial blood pressures decreased in the sildenafil group both at rest and during 
submaximal exercise. No patient reported serious adverse events after sildenafil.
Conclusions: In Fontan patients, oral administration of a single dose of sildenafil improves 
exercise capacity and hemodynamic response to exercise.
ACC.POSTER CONTRIBUTIONS
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9:00 a.m.
1032-117 Effect of Bosentan on Patients With Eisenmenger 
Syndrome
Kasper Iversen, Annette S. Jensen, Niels G. Vejlstrup, Lars Soendergaard, 
Rigshospitalet, Copenhagen, Denmark
Background: Eisenmenger syndrome causes severe physical limitation, and until recently 
treatment options have been very limited. However, the introduction of pulmonary 
vasodilatators may offer a new therapeutic option for this patient group. The aim of this 
study was to investigate the effects of the dual endothelin receptor antagonist Bosentan 
in patients with Eisenmenger syndrome. Endpoints were defined as 6 minutes walk test 
(6 MWT), pulmonary blood flow, pulmonary vascular resistance (PVR) and N-terminal 
proBNP (BNP).
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Method: Prospective study of 21 patients with Eisenmenger syndrome (mean age 43.5, 
range 46 years; 7 were men). The patients were treated with Bosentan 125 mg bid for 2 
weeks and afterwards 250 mg bid for 10 weeks. All patients underwent 6 MWT and cardiac 
catheterisation at baseline as well as after the 12 weeks treatment with Bosentan.
Results: There were a significant improvement in 6 MWT (377 m vs. 413 m, p=0.001), 
pulmonary blood flow (2.7l vs. 3.7l, p=0.009) and PVR (28 woods vs. 21 woods, p=0.007) 
during treatment with Bosentan (Figure). There was a non-significant decrease in BNP 
(87 pmol/l vs. 71 pmol/l, p=0.11). No side effects including elevation of liver transaminases 
were observed.
Conclusion: Bosentan offers patients with Eisenmenger syndrome similar effects as 
reported for other groups with pulmonary arterial hypertension. Most patients with 
Eisenmenger syndrome are severely symptomatic so a widespread use of pulmonary 
vasodilatators in this patient group can be foreseen. 
9:00 a.m.
1032-118 Closure of Atrial Septal Defects Reduces, but does Not 
Abolish the risk of Recurrent Cerebrovascular Events
Sjoukje I. Lok, Konstantinos Dimopoulos, Bjorn Winkens, Michael A. Gatzoulis, Barbara 
J. Mulder, Academisch Medisch Centrum, Amsterdam, The Netherlands, Royal 
Brompton Hospital, London, United Kingdom
Background: Patients with an ischemic cerebrovascular accident or transient ischemic 
attack (CVA/TIA) and an atrial septal defect (ASD) are at increased risk for recurrent 
events. The aim of this study was to assess the effect of ASD closure on the risk of 
recurrent CVA/TIA.
Methods: Patients with an ASD born after 1950 who had a CVA/TIA were included in this 
multicenter, retrospective study performed in the Netherlands and the UK.
Results: Sixty-four patients (mean age 33.0 years, sd 11.3, 31.3 % male) were included, 
of whom 37 (57.8%, group I) had ASD closure (51.3 % device, 48.7 % surgical) and 27 
(42.2 %, group II) were either on antiplatelets (40.7 %), anticoagulants (44.4 %) or no 
medical therapy (14.9 %). Patients in group II were more likely to have a family history 
of acquired cardiovascular disease (OR 4.95, 95 % CI: 1.29 - 19.01, p = 0.02). During 
a median follow-up of 50 months, 19 (29.7%) patients had recurrent cerebrovascular 
events, 5 in group I and 14 in group II. Patients in group II had a significantly higher risk 
of a recurrent stroke (HR 4.31, 95 % CI: 1.52 - 12.17, p=0.006). However, even repaired 
patients had a 11 % cerebrovascular recurrence rate at 5 years, albeit a small residual 
shunt was present in 3 out of 5 of them.
Conclusions: Closure of ASD significantly reduces the risk of recurrent CVA/TIA. 
Cerebrovascular events, however, recurred even after closure. This was associated with 
small residual shunting in some, but not all patients suggesting a possible left-sided 
pathogenetic mechanism. 
9:00 a.m.
1032-119 Reoperation after the Ross Procedure: Spectrum, 
Challenges, and Outcome
John M. Stulak, Thoralf M. Sundt, III, Hartzell V. Schaff, Heidi M. Connolly, Joseph A. 
Dearani, Mayo Clinic College of Medicine, Rochester, MN
Background: Freedom from postoperative anticoagulation, excellent hemodynamics, 
and increased freedom from reoperation are argued advantages of the Ross pulmonary 
autograft procedure. With time, however, experience with repeat operations following the 
Ross procedure is increasing.
Methods: We reviewed 34 consecutive patients undergoing reoperation following the Ross 
procedure between September 1991 and July 2006; 27 patients had initial operation elsewhere. 
The median age at index operation (first reoperation at our institution) was 29 years (range 1-
69) and the median time interval between the original Ross procedure and index reoperation 
was 28 months (range 1-134 months). The four most common indications for reoperation 
were aortic regurgitation/stenosis in 21 (57%), pulmonary conduit regurgitation/stenosis in 16 
(43%), and autograft aneurysm and tricuspid regurgitation in 7 (19%) each.
Results: In all, 83 procedures were performed in these 34pts. Operations on the left heart 
included aortic valve replacement in 15pts (44%), ascending aorta/arch reconstruction 
in 9 (26%), and aortic root replacement in 8 (24%); right-sided procedures included 
pulmonary valve replacement in 15 (44%), right ventricular outflow tract reconstruction 
in 14 (41%), and tricuspid valve surgery in 8 (24%). Early mortality was 3% and early 
complications included respiratory failure in 6pts, renal dysfunction and ECMO in 2 each. 
Three patients underwent further reoperation, and there were 2 late deaths during a 
median follow-up of 20 months (max. 179 months).
Conclusions: The broad spectrum of reoperations following the Ross Procedure includes 
both left- and right-sided procedures. Early mortality and morbidity are not insignificant, 
and a number of patients require numerous subsequent interventions. Accordingly, 
patients and family members should be advised of the reoperative procedures which may 
be required following the Ross pulmonary autograft procedure.
9:00 a.m.
1032-120 Role of Venous to Arterial Circulation Shunts in 
Migraine - a Case Control Study
Uma M. Velupandian, Eleanor Herring, Simon G. Ray, Charles Sherrington, Brendan 
Davies, Zoe Bonner, Julie Morris, Gary J. Macfarlane, Charles McCollum, University 
of Manchester, Manchester, United Kingdom, University Hospital, South Manchester, 
Manchester, United Kingdom
Background: Venous-to-arterial circulation shunts(vaCS) usually a Patent Foramen 
Ovale(PFO) may trigger migraine by allowing microemboli or vasoactive peptides to pass 
through. This is suggested by reports of improvement in migraine after PFO closure and 
migraine reported in divers with PFO during decompression. We aimed to investigate the 
frequency of vaCS in migraine with aura(M+A), migraine without aura(M-A) and healthy 
controls matched by age and sex to M+A.
Methods: Adults aged 18-59 years with M+A(n=62), M-A(n=62) and healthy controls(n=62) 
matched to M+A were investigated using transcranial Doppler with microbubble contrast 
injection at rest, with cough and a standardised valsalva manoeuvre(VM). Shunts were 
graded by microbubble count as minor (1-14), clinically significant (>15) and major (>50 
at rest or >10 at rest with >80 with cough/VM).
Results: The frequency of vaCS in M+A, M-A and Controls was 50%, 25.8% and 27.4%. 
A significant difference was noted between M+A and matched controls in the prevalence 
of i) vaCS ( p=0.024), ii) clinically significant shunt (p=014) iii) major shunt(p=0.013) and 
iv) spontaneous shunt at rest (p=0.029). No statistical difference in prevalence was noted 
between M-A and Controls.
Conclusions: There is a significant association between vaCS and M+A. Clinically 
significant shunting of microemboli or vasoactive peptides through a vaCS may trigger 
M+A especially when the shunt is major or spontaneous.
Table 1: Frequency of vaCS in migraine subjects and controls 
Frequency of vaCS
n/total n (%)
Statistics
M+A Controls matched to M+A M-A
Any Shunt 31/62(50%)
17/62
(27.4%)
16/62
(25.8%)
M+A versus Controls 
p=0.024
M-A versus Controls
p = 1.000(NS)
Clinically 
significant shunt
27/62
(43.5%)
12/62
(19.4%)
12/62
(19.4%)
M+A versus Controls 
p=0.014
Major shunt 16/46(35.8%)
5/62
(8.1%)
6/62
(9.7%)
M+A versus Controls 
p=0.013
Spontaneous 
Shunt at rest
22/62
(35.5%)
10/62
(16.1%)
7/62
(11.3%)
M+A versus Controls
p = 0.029
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9:00 a.m.
1032-121 Sexual Dysfunction in Men with Congenital Heart 
Disease: Underreported and Rarely Discussed
Stephen C. Cook, Lindsay M. Arnott, Lindsey R. Cook, Lisa M. Nicholson, Elizabeth A. 
Sparks, Curt J. Daniels, Nationwide Children’s Hospital, Columbus, OH
Background: There has been a tremendous focus on gynecologic health with the 
increasing number of women with congenital heart disease (CHD) now reaching child-
bearing age. Conversely, experience in providing similar sexual health screening to men 
with CHD is lacking. The purpose of this study was to identify sexual health issues in 
men with CHD.
Methods: An anonymous survey was distributed to fifty-one men in the Adult CHD clinic. 
Age, type of CHD, level of education, medication history, detailed sexual history including 
cardiac symptoms with sex, impotence and/or erectile dysfunction (ED) and willingness to 
discuss ED with a physician was obtained. A logistic regression analysis was performed 
to analyze the relationship between medications and ED.
Results: Fifty-one men completed the survey. The mean age was 33 ± 9 years. There 
were 10 men with simple CHD, 22 with CHD of moderate severity, 8 with complex CHD 
and 11 who did not know their CHD. Most men graduated from high school (52%) or 
had a college degree (40%). Thirty were treated with cardiac medications including beta-
blockers (BB; n=22), angiotensin-converting enzyme inhibitors (ACEI; n=11), calcium-
channel blockers (CCB; n=3) and 8 men were unable to report their medications. The 
prevalence of ED was 33%. Over half (55%) reported sexual activity induced symptoms 
of palpitations, fatigue, shortness of breath or chest pain. As age increased, the odds of 
reporting ED increased (p=0.04). No significant associations were observed for BB or 
ACEI and ED but a slightly higher risk was present for men using CCB (p=0.05). Over half 
(58%) attributed these symptoms to their underlying CHD. Most men (68%) reported they 
would discuss issues of ED with their cardiologist.
Conclusions: Sexual health issues, notably ED, are prevalent in young men who have 
CHD. A complex emotional and physiologic interaction may attribute to this constellation of 
symptoms. However, questions and fears regarding sexual health may not be expressed 
voluntarily. Therefore, discussion of this sensitive but important topic should be initiated 
with the physicians and nurses who care for this unique population of patients.
9:00 a.m.
1032-122 Fate of Functional Tricuspid Regurgitation in Adults 
After Closure of Atrial Septal Defects Without Any 
Tricuspid Valve Procedures
Manatomo Toyono, Richard A. Krasuski, Gosta B. Pettersson, Yoshiki Matsumura, 
Tetsuhiro Yamano, James D. Thomas, Takahiro Shiota, Cleveland Clinic, Cleveland, OH
Background: Little is known about the fate of functional tricuspid regurgitation (TR) after 
closure of atrial septal defect (ASD). We investigated the fate of functional TR after ASD 
closure and predictors of persistent TR.
Methods: We examined 32 consecutive patients (54 ± 18 years) with moderate or severe 
TR before ASD closure during the last 5 years. Echocardiography was performed to 
obtain left ventricular ejection fraction, right ventricular (RV) fractional area change, right 
atrial area, minimal tricuspid valve (TV) annular diameter, TV tethering height, RV systolic 
pressure and the pulmonary to systemic blood flow ratio before and after surgery (5 ± 5 
days). TR severity was assessed by maximal TR jet area. Moderate TR was defined as 
TR jet area >5 cm2.
Results: Twenty-three patients underwent percutaneous ASD closure while 9 patients 
underwent isolated surgical ASD closure. TR jet area had a tendency to decrease after 
percutaneous (from 11 ± 10 to 6 ± 5 cm2) and surgical closure (from 9 ± 5 to 6 ± 5 
cm2) (both p >0.06). Multivariate analysis revealed that only pre-procedural RV systolic 
pressure was linearly related to post-procedural TR jet area (Figure). RV systolic pressure 
of >60 mm Hg predicted persistent TR with sensitivity of 100% and specificity of 63%.
Conclusion: TR tended to decrease after ASD closure without TV surgery. Increased RV 
pressure predicted persistent TR after ASD closure. TV surgery may be recommended in 
ASD patients with moderate or severe TR and RV pressure overload. 
9:00 a.m.
1032-123 Partial Anomalous Pulmonary Venous Connections in 
Adults: Twenty-Year Experience
David S. Majdalany, Sabrina D. Phillips, Joseph A. Dearani, Heidi M. Connolly, Carole A. 
Warnes, Mayo Clinic, Rochester, MN
Background: Isolated partial anomalous pulmonary venous connections (PAPVC), like 
secundum atrial septal defects (ASD), can cause right ventricular (RV) volume overload 
and symptoms. The management is controversial in view of surgical complexity.
Methods: We reviewed all isolated PAPVC patients (pt) >18 yr attending the Adult 
Congenital Clinic from 1988-2007. Pt were excluded if they had other structural heart 
disease.
Results: There were 43 pt (20 males) aged 20-73 yr. Fifteen pt did not have surgery; 12 
had no RV volume overload, 2 had comorbidities precluding surgery, and one declined. 
Eleven of the unoperated pt had a single anomalous pulmonary vein (PV), including one 
with scimitar syndrome; 4 had scimitar syndrome with two anomalous PV.
Surgical repair was performed in 28 pt aged 24-73 yr (mean 44); 27 pt had RV volume 
overload and 1 pt had obstructed veins. Of 28 pt, 21 (75%) had >1 anomalous PV. 
Symptoms included fatigue (43%), dyspnea (39%), and palpitations (29%). Five pt had 
no symptoms; 4 had ≥moderate RV enlargement, one had obstructed PV. Twelve pt had 
RV systolic pressure >35 mmHg on echo.
Eleven pt (39%) had anomalous left PV: 10 pt had the PV anastomosed to the left atrial 
appendage off bypass via left thoracotomy and one pt had anastomosis to the left lower PV. 
Sixteen pt (46%) had anomalous right PV: 13 to the superior vena cava and 3 had scimitar 
syndrome. Fifteen pt had a baffle through a surgically created ASD; 1 had the anomalous 
PV anastomosed to the left atrium directly. One pt had both right and left anomalous PV 
repaired by direct anastomosis of the confluence to the left atrium. There was no surgical 
mortality. Nineteen pt (68%) had reduction in their RV size and 5 had improved RV function. 
Seven of the 12 pt with RV systolic pressure >35 mmHg before repair had a decrease 
postoperatively. Follow-up ranged from 5 mos to 10 yr (mean 2.7 yr). One pt had a trivial 
baffle leak on echo and one pt needed reoperation for baffle obstruction.
Conclusion: PAPVC can cause symptoms, RV volume overload, and increased pulmonary 
pressures particularly when >1 PV is anomalous. Surgical repair can be accomplished 
with very low morbidity and mortality, with improvement in the RV size and pulmonary 
pressures in the majority.
9:00 a.m.
1032-124 Comparison of Long-term Clinical Outcomes in Patients 
with Anomalous Aortic Origins of the Coronary Arteries 
Based Upon Passage Between the Great Vessels
Dari Magyar, Stephen Hart, Sagar Kalahasti, Stephen Gimpel, Yuli Kim, Robert Hobbs, 
Richard Lorber, Gosta Pettersson, Richard A. Krasuski, The Cleveland Clinic, Cleveland, 
OH, Case Western Reserve University, Cleveland, OH
Background: An anomalous aortic origin of the coronary arteries (AAOC) is believed to 
increase the risk of sudden death, particularly when coronaries pass between the great 
vessels. Unfortunately much of this prior risk assessment comes from tiny surgical and 
autopsy series.
Methods: We reviewed over 200,000 cardiac catheterizations in the Cleveland Clinic 
Cardiovascular Registry and identified those patients with AAOC, either the right coronary 
artery from the left cusp (RCA-LC) or the left main coronary artery from the right cusp 
(LMA-RC). Patients were stratified by confirmed interarterial course between the great 
vessels (IAC). Survival was assessed using the Social Security Death Index.
Results: Among the 301 patients with AAOC, 79% were RCA-LC and 21% were LM-
RC. 18% were confirmed to have an interarterial course. Patients with IAC were younger 
at presentation (53±13 vs. 60±14 years, p=0.044) and tended to have less extensive 
atherosclerosis (1.1±0.9 vs. 1.4±1.2 vessels involved, p=0.069), but all other observed 
features (diabetes, smoking, chest pain, shortness of breath, history of myocardial 
infarction) were similar between groups. 52% of patients with IAC underwent surgery 
compared to 27% of those without IAC, p<0.001. Follow-up was over 125±98 months in 
the IAC group vs. 141±125 months in patients without IAC, p=NS. Mortality was actually 
higher in those patients without IAC (46%) than those with IAC (31%), p=0.046; and this 
difference remained present after adjustment for baseline differences.
Conclusions: Interarterial course of anomalous coronary arteries in this single-center 
cohort study does not appear to predict worsened clinical outcome in patients with 
anomalous aortic origin of the coronary arteries.
9:00 a.m.
1032-125 LV long-axis dysfunction in adult patients with 
“corrected” aortic coarctation is related to a later age 
of intervention and increased aortic stiffness
Yat Yin Lam, Michael Mullen, Wei Li, Michael Y. Henein, Chinese University of Hong 
Kong, Hong Kong, Hong Kong, Royal Brompton Hospital, London, United Kingdom
Background: Little is published about LV long-axis dysfunction in adult patients with 
“corrected” (surgical repair or endovascular stenting) aortic coarctation. We sought to 
examine the prevalence of LV long-axis dysfunction (septal annular pulsed wave [PW] 
tissue Doppler imaging [TDI] early diastolic velocity <8 cm/s) in these patients and its 
relationship to patient demographics and indices of aortic stiffness.
Methods: A total of 64 consecutive patients (aged 36+ 9 years, 30 stented and 34 
repaired) with aortic coarctation referred to Royal Brompton Hospital from 2002 to 
2005 were retrospectively studied. Patient demographics including age of intervention, 
co-morbidities, systemic blood pressure and medications were recorded. The LV 
(septal annulus motion) long-axis movement was measured by M-mode and PW TDI. 
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Aortic strain and distensibility were calculated from the aortic diameters measured by 
echocardiography and blood pressure obtained by sphygmomanometry.
Results: Forty-one patients (64%) had LV long-axis dysfunction. They were older at age 
of intervention, had higher left ventricular mass, less aortic strain (8.1+ 2.1 vs 12+3.2 %) 
and distensibility (3.1+1.8 vs 5.5+2.1 cm2/dyn/103; p<0.01 for all) compared with other 
coarctation patients despite similar prevalence of hypertension, anti-hypertensive use 
and associated biscuspid aortic valves. The age of intervention (OR 4.3, 95% CI 1.07 
- 13.41, p<0.01) and aortic distensibility (OR 0.88, 95% CI 0.67 - 0.96, p<0.01) were 
the two independent parameters for LV long-axis dysfunction in patients on multivariate 
analysis.
Conclusions: LV long-axis dysfunction is common in adult patients with aortic coarctation 
despite apparently successful repair or stenting. Its presence is related to a later age 
of intervention and increased aortic stiffness. Early removal of outflow tract obstruction 
before irreversible damage to proximal aorta occurs might preserve long-axis function in 
these patients
